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1 INTRODUCTION 
 
1.1 Cadmium: characteristics and physical-chemical properties 
 
 
Cadmium is a chemical element with the symbol Cd and atomic number 
48. Cadmium is a soft, malleable, ductile, bluish-white bivalent metal;  it is 
chemically similar to the two 
other metals in group 12 
(IUPAC style; group II B), zinc 
and mercury. Similar to zinc it 
prefers oxidation state +2 in 
most of its compounds and similar to mercury it shows a low melting point 
compared to transition metals. Cadmium and its congeners are not 
considered transition metals, in that they do not have partly filled d or f 
electron shells in the elemental or common oxidation states [Cotton, 1999]. 
Average concentration in the earth’s crust is between 0.1 and 0.5 parts per 
million (ppm). It was discovered simultaneously by Stromeyer and 
Hermann, both in Germany, as an impurity in zinc carbonate [1]. 
Cadmium occurs as a minor component in most zinc ores and therefore is a 
byproduct of zinc production. Cadmium was used for a long time as a 
pigment and for corrosion resistant plating on steel. Cadmium compounds 
were used to stabilize plastic. With the exception of its use in nickel-
cadmium batteries and cadmium telluride solar panels, the use of cadmium 
Cadmium bar (purity 99.999 %) 
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is generally decreasing in its other applications. These declines have been 
due to competing technologies, cadmium’s toxicity in certain forms and 
concentration and resulting regulations [2]. Although cadmium is toxic, one 
enzyme, a carbonic anhydrase with cadmium as reactive center has been 
discovered. 
It is similar in many respects to zinc but forms complex compounds 
[Holleman et al., 1985]. The most common oxidation state of cadmium is 
+2, though rare examples of +1 can be found. Cadmium burns in air to 
form brown amorphous cadmium oxide (CdO). The crystalline form of the 
same compound is dark red and changes color when heated, similar to zinc 
oxide. Hydrochloric acid, sulfuric acid and nitric acid dissolve cadmium by 
forming cadmium chloride (CdCl2) cadmium sulfate (CdSO4) or cadmium 
nitrate (Cd(NO3)2). 
Naturally occurring cadmium is composed of 8 isotopes. For two of them, 
natural radioactivity was observed, and three others are predicted to be 
radioactive but their decay is not observed, due to extremely long half-life 
times. The two natural radioactive isotopes are 113Cd and 116Cd. The other 
three are 106Cd, 108Cd and 114Cd; only lower limits on their half-life times 
have been set. At least three isotopes - 110Cd, 111Cd, and 112Cd - are stable. 
Among the isotopes absent in natural cadmium, the most long-lived are 
109Cd and 115Cd. All of the remaining radioactive isotopes have very short 
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half-lives. This element also has 8 known meta states, with the most stable 
being 113mCd, 115mCd, and 117mCd. 
The known isotopes of cadmium range in atomic mass from 94.950 u 
(95Cd) to 131.946 u (132Cd). For isotopes lighter than 112 u, the primary 
decay mode is electron capture and the dominant decay product is element 
47 (silver). Heavier isotopes decay mostly through beta emission producing 
element 49 (indium). 
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Silver ← Cadmium → Indium 
 
Zinc 
↓ 
Cadmium 
↓ 
Mercury 
 
Periodic table of the chemical elements 
 
 
 
 
 
 
 
Summary table of Cadmium properties  
Miscellanea 
Electronegativity 1.69 (Pauling scale) 
Specific heat capacity 26.020 J/(mol*K) 
Electrical resistivity 72.7 nΩ*m 
Thermal conductivity 96.6 W/(m*K) 
1st ionization energy 867.8 kJ/mol 
2nd ionization energy 1631.4 kJ/mol 
3rd ionization energy 3616 kJ/mol 
General properties 
Name, Symbol, Atomic number cadmium, Cd, 48 
Element category Transition metal 
Group, Period, Block 12, 5, d 
Density, Mosh Hardness 8650 kg/m3, 2 
Aspect Bluish-white metal 
Most stable isotopes 
iso NA TD DM DE DP 
108Cd 0,89% Cd is stable with 60 neutrons 
109Cd Syn 462.6 daysni ε 0,214 109Ag 
110Cd 12,49% Cd is stable with 62 neutrons 
111Cd 12,8% Cd is stable with 63 neutrons 
112Cd 24,13% Cd is stable with 64 neutrons 
113Cd Syn 7.7×1015 years β- 0,316 113In 
113Cdm Syn 14.1 years β
- 
IT 
0,580 
0,264 
113In 
  
114Cd 28.73% Cd is stable with 66 neutrons 
116Cd 7.49% Cd is stable with 68 neutrons 
 
Atomic properties 
Standard atomic weight 112.411 g/mol 
Atomic radius 151 pm 
Covalent radius 148 pm 
Vn der Waals radius 158 pm 
Electron configuration [Kr]4d10 5s2 
Electrons per shell 2, 8, 18, 18, 2 
Oxidation states 2, 1 (milly basic oxide) 
Crystal structure Hexagonal 
Physical properties 
Room temperature status Solid 
Melting point 594.22 K (321.07 °C) 
Boiling point 1040 K (767 °C) 
Molar volume 13.00×10-6 m3/mol 
Heat of vaporization 100 kJ/mol 
Heat of fusion 6.192 kJ/mol 
Vapor pressure 14.8 Pa a 597 K 
Speed of sound 2310 m/s at 293.15 K 
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1.2 Cadmium: history 
 
 
Cadmium (Latin cadmia, Greek καδμεία meaning 
"calamine", a cadmium-bearing mixture of 
minerals, which was named after the Greek 
mythological character, Κάδμος Cadmus, the 
founder of Thebes) was discovered simultaneously 
by Friedrich Stromeyer [Hermann, 1818] and Karl 
Samuel Leberecht Hermann, both in Germany, as 
an impurity in zinc carbonate [2]. Stromeyer found the new element as an 
impurity in zinc carbonate (calamine), and, for 100 years, Germany 
remained the only important producer of the metal. The metal was named 
after the Latin word for calamine, since the metal was found in this zinc 
compound. Stromeyer noted that some impure samples of calamine 
changed color when heated but pure calamine did not. He was persistent in 
studying these results and eventually isolated cadmium metal by roasting 
and reduction of the sulfide. Even though cadmium and its compounds may 
be toxic in certain forms and concentrations, the British Pharmaceutical 
Codex from 1907 states that cadmium iodide was used as a medication to 
treat "enlarged joints, scrofulous glands [Dunglison, 1866], and chilblains". 
In 1927, the International Conference on Weights and Measures redefined 
the meter in terms of a red cadmium spectral line (1 m = 1,553,164.13 
wavelengths) [Burdun, 1958]. This definition stood unchanged until 1960. 
Friedrich Stromeyer 
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After the industrial scale production of cadmium started in the 1930s and 
1940s the major application was the coating of iron and steel to prevent 
corrosion [2]. In 1944, 62% and in 1956 59% of the cadmium in the United 
States was used for this purpose [Lansche, 2008]. The second application 
was red, orange and yellow pigments based on sulfides and selenides of 
cadmium. In 1956, 24% of the cadmium used within the United States was 
used for this purpose [Lansche, 2008]. The stabilizing effect of cadmium-
containing chemicals (carboxylates such as the laureate and the stearate) on 
PVC led to a increased use of those compounds in the 1970s and 1980s. 
The use of cadmium in applications such as pigments, coatings, stabilizers 
and alloys declined due to environmental and health regulations in the 
1980s and 1990s. In 2006, only 7% of total cadmium consumption was 
used for plating and coating and only 10% was used for pigments [2]. The 
decrease in consumption in other applications was made up by a growing 
demand of cadmium in nickel-cadmium batteries, which accounted for 
81% of the cadmium consumption in the United States in 2006 [3].  
 
 
1.3 Cadmium: occurrence and applications 
 
 
Cadmium-containing ores are rare and are found to occur in small 
quantities (about 0.1-0.5 mg/kg of the Earth's Crust). However, traces do 
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naturally occur in phosphate, and have been shown to transmit in food 
through fertilizer application [Jiao et al., 2004]. Greenockite (CdS), 
the only cadmium mineral of importance, is 
nearly always associated with sphalerite 
(ZnS). As a consequence, cadmium is 
produced mainly as a byproduct from mining, 
smelting, and refining sulfidic ores of zinc, 
and, to a lesser degree, lead and copper. 
Small amounts of cadmium, about 10% of 
consumption, are produced from secondary sources, mainly from dust 
generated by recycling iron and steel scrap. Production in the United States 
began in 1907, but it was not until after World War I that cadmium came 
into wide use [Plachy, 2010; Fthenakis, 2004]. One place where metallic 
cadmium can be found is the Vilyuy River basin in Siberia [Fleischer, 
1980].  
In 2009, 86% of all the cadmium is used in batteries, predominantly in 
rechargeable nickel-cadmium batteries. The European Union banned the 
use of cadmium in electronics in 2004 with several exceptions but reduced 
the allowed content of cadmium in electronics to 0.002% [4]. 
Most of cadmium which is not consumed in battery production is used 
mainly for cadmium pigments, coatings and plating. Examples of some 
uses include: 
Greenockite crystals from 
Tsumeb Mine, Namibia 
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• In electroplating (6% cadmium) [Scoullos et al., 2001] due to the 
excellent corrosion resistance of cadmium-plated steel components.  
• Helium-cadmium lasers are a popular source of blue-ultraviolet laser 
light used in fluorescence microscopes and various laboratory 
experiment [5].  
• Cadmium is used as a barrier to control neutrons in nuclear fission 
[Scoullos et al., 2001]. 
• Cadmium oxide in black and white television phosphors and in the 
blue and green phosphors for color television picture tubes [Lee et 
al., 2002].  
• Cadmium sulfide (CdS) as a photoconductive surface coating for 
photocopier drums [Miller et al., 1991]. 
• In paint pigments, cadmium forms various salts, with CdS being the 
most common. This sulfide is used as a yellow pigment. Cadmium 
selenide can be used as red pigment, commonly called cadmium red.  
• Cadmium is a component of some compound semiconductors. 
• In PVC as heat, light, and weathering stabilizers [Scoullos et al., 
2001; Jennings, 2005]. 
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1.4 Cadmium: biological role 
 
Cadmium has no known useful role in higher organisms [Hogan, 2010]. A 
role for cadmium in lower lifeforms has recently been found. A cadmium-
dependent carbonic anhydrase has been found in marine diatoms. Cadmium 
performs the same function as zinc in other anhydrases, but the diatoms 
live in environments with very low zinc concentrations and thus the 
biological system has utilized cadmium in place of zinc to perform that 
function normally carried out by zinc. The discovery was made using X-ray 
absorption fluorescence spectroscopy (XAFS), and cadmium was 
characterized by noting the energy of the X-rays that were absorbed [Lane 
et al. 2000 and 2005]. 
 
 
1.5 Cadmium: human exposure 
 
The general population is exposed to cadmium from multiple sources. 
Attention is drawn to the following (UNEP, 2008): 
 
• in the non-smoking general population, food accounts for 
approximately 90 %. The main food commodities that contribute to 
cadmium exposure are cereals and vegetables. 
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• cadmium in crops depends on uptake from soils and the rate of 
uptake is influenced principally by the forms of the element, the soil 
physico-chemical properties and the plant species. 
• meat and fish normally contain lower cadmium contents. Animal 
offals such as kidney and liver can exhibit high cadmium 
concentrations, as these are the organs in animals in which cadmium 
concentrates (UNEP, 2008). 
 
Less than 10 % of total exposure of the non-smoking general population 
occur due to inhalation of the low concentrations of cadmium in ambient 
air (Vahter et al., 1991) and through drinking water (Olsson et al., 2002). If 
present, smoking and occupational exposure may prevail over food as the 
main sources of cadmium exposure. Smokers have on average twice the 
body burden of a non-smoker. Workers may accumulate much higher 
cadmium levels depending on the type of work. The sources of human 
exposure to cadmium include industry emissions and contamination of 
different environmental media, i.e. air, water and soil. The latter may also 
be contaminated by fertilisers. Cadmium contamination of the environment 
leads to subsequent food contamination, especially in case of cereals and 
vegetables. 
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1.5.1 Occupational exposure 
 
Workers may be exposed to cadmium and cadmium compounds in a 
variety of occupational settings (Table 1).  
 
Alloy productiona 
Battery productiona 
Brazing 
Coating 
Diamond cutting 
Dry colour formulation 
Electroplating 
Electrical contacts production 
Enamelling 
Engraving 
Glasswork 
Laser cutting 
Metallizing 
Paint production and use 
Pesticide production and use 
Phosphorus production 
Pigment production and usea 
Plastics productiona 
Plating 
Printing 
Semiconductor and superconductor production 
Sensors production 
Smelting and refininga 
Solar cells production 
Soldering 
Stabilizer production 
Textile printing 
Thin film production 
Transistors production 
Weldinga 
 
   aActivities in which risk is highest because atmospheric concentrations 
of cadmium can be high and because the number of workers employed 
is relevant (modified from Odone et al., 1983). 
 
Table 1. Occupations in which there is potential exposure 
to cadmium and cadmium compounds. 
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The major sources of such exposure are smelting and refining of zinc, lead 
and copper ores, electroplating, manufacture of cadmium alloys and of 
pigments and plastic stabilizers, production of nickel-cadmium batteries 
and welding. Airborne concentrations of cadmium found in occupational 
settings vary considerably according to the type of industry and to specific 
working conditions. Cadmium oxide fumes are generated at high 
temperatures (US Occupational Safety and Health Administration, 1992) 
and can be absorbed very efficiently through the lung, while deposition and 
absorption of dust of different cadmium compounds depends on particle 
size (Alessio et al., 1983; Thun et al., 1991). 
 
1.5.2 Air 
 
Industrial activities are the main sources of cadmium release to the air and 
emissions from anthropogenic sources have been found to exceed those of 
natural origin by an order of magnitude (ATSDR, 1999). Cadmium and 
cadmium compounds have negligible vapour pressures but may exist in air 
as suspended particulate matter derived from sea spray, industrial 
emissions, combustion of fossil fuels, or the erosion of soils (Elinder, 
1985). In processes that involve extremely high temperatures (e.g., the iron 
and steel industries), cadmium can volatilize and be emitted as a vapour 
(Wilber et al., 1992). Total emission to air from natural sources (mainly 
volcanoes) is estimated at about 150-2,600 tonnes per year. These figures 
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may be compared to an estimate of total anthropogenic air emission in 
1995 of approximately 3,000 tonnes (Nordic Council of Ministers, 2003). 
The largest source of atmospheric cadmium is non-ferrous metal 
production, which contributes about 75 % of total anthropogenic cadmium 
emissions (Pacyna and Pacyna, 2001). In urban areas of the EU, cadmium 
concentrations in air are in the range between 1 and 10 ng/m3. Atmospheric 
cadmium is in the form of particulate matter, which may consist of very 
small particles (<10 μm) if it is produced by combustion processes. The 
principal chemical species in air is cadmium oxide, although some 
cadmium salts, such as cadmium chloride, used as stabilizers and pigments 
in plastics, can enter the air, especially during incineration (IARC, 1993).  
As a matter of fact traditional municipal solid-waste incinerators may make 
a significant contribution to the concentration of cadmium in ambient air 
and to its deposition rates. The rates of emission of cadmium from 
incinerators in Europe, Canada and the USA ranged from 20 to 2000 µg/m3 
from the stacks of traditional incinerators and from 10 to 40 µg/m3 from 
advanced incinerators. Cadmium pollutants present in the air may be 
transported from a hundred to a few thousand kilometres and have a typical 
atmospheric residence time of about l-10 days before deposition occurs by 
wet or dry processes (Elinder, 1985; ATSDR, 1999). 
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1.5.3 Water environment 
 
Cadmium enters the aquatic environment from numerous diffuse and point 
sources and by different routes. 
At the global level, the smelting of nonferrous metal ores has been 
estimated to be the largest human source of cadmium released into the 
aquatic environment (Nriagu & Pacyna, 1988). The cadmium content of 
ore bodies, mine management policies and climatic and geographical 
conditions all influence the quantities of cadmium released from individual 
sites. Contamination can arise from entry into aquifers of mine drainage 
water, wastewater, overflow from tailing ponds and rainwater run-off from 
mine areas (WHO, 1992a). Other human sources are spent solutions from 
plating operations and phosphate fertilizers, which are known to contain 
cadmium. Atmospheric fall-out of cadmium to water courses and marine 
waters represents the major worldwide source of cadmium in the 
environment (Nriagu & Pacyna, 1988). Acidification of soils and lakes may 
result In mobilization of the metal from soils and sediments toward surface 
and groundwaters (Impens et al., 1989; WHO, 1992b). Other point sources 
are mining residue dumps, solid-waste deposits and wastewater of both 
municipal and industrial origin (Muntau & Baudo, 1992). The average 
cadmium content of seawater is about 5-20 ng/L in open seas, but increased 
concentrations of 80-250 ng/L have been reported in French and 
Norwegian coastal zones. Concentrations measured in European rivers 
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generally vary between 10 and 100 ng/L (OSPAR, 2002).The concentration 
of cadmium in drinking-water is generally less than 1 µg/L, but it may 
increase up to 10 µg/L as a result of industrial discharge and leaching from 
metal or plastic pipes (Friberg et al., 1971). 
 
1.5.4 Soil and plants 
 
The sources of cadmium in soil are nonferrous metal mines and smelters, 
agricultural application of phosphate fertilizers, use of batteries, PVC 
stabilizers, pigments and alloys, sewage-sludge landfill, sewage-sludge and 
solid-waste incineration, and application of municipal sewage sludge to 
agricultural soil (UNEP, 1984, 1992; WHO, 1992a,b). Atmospheric 
cadmium deposition onto soil has generally decreased over the last 20 years 
in Europe. Recent studies have documented that atmospheric emissions do 
not presently have a significant impact upon the cadmium content of soils 
(Bak et al., 1997). The cadmium content of fertilisers depends on its 
concentration in the raw material used for the production. Nevertheless 
there is currently no EU legislation limiting the maximum level of 
cadmium in fertilizers but some countries have permanent exceptions to 
use national guidelines. The concentration of cadmium in soil can vary 
widely. In non-polluted are as, concentrations are usually below 1 mg/kg 
(Friberg et al., 1971, 1974), whereas in polluted areas levels of up to 800 
mg/kg have been detected (Friberg et al., 1985; 1986b; WHO, 1992b). 
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Since cadmium is taken up by plants, an increased soil concentration can 
result in increased levels in food and feeds (UNEP, 2006). However, the 
concentration of cadmium in soils is not the primary determinant of 
cadmium in plants. Cadmium is much less mobile in soils than in air and 
water. Cadmium residues in plants are normally less than 1 mg/kg (Friberg 
et al., 1986a); however, plants growing in soil contaminated with cadmium 
may contain significantly higher levels (UNEP, 1984, 1992; WHO, 1992b). 
 
1.5.5 Cigarette smoke 
 
Tobacco plants naturally accumulate relatively high concentrations of 
cadmium in the leaves. The cadmium content of cigarette tobacco is 
generally 1-2 µg per cigarette, although the concentrations differ among 
regions. A smoker who smokes 20 cigarettes per day has an estimated daily 
uptake of 2-4 µg and accumulates 0.5 mg cadmium in one year (Lewis et 
al., 1972; UNEP 1984; Friberg et al., 1985; IARC, 1986a; UNEP, 1992; 
WHO, 1992b). 
 
1.5.6 Food 
 
A number of studies have reviewed cadmium content in a range of different 
foods. In a collaborative effort under the SCOOP involving 13 EU Member 
States, cadmium concentrations ranged from non-detected in many foods to 
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a high mean of 1.20 mg/kg for cephalopods (EC, 2004a). Meat, eggs, fish 
and milk products generally contain little cadmium (less than 0.01 µg/g wet 
weight) whereas internal organs, especially liver and kidney, may contain 
mach more. In general, vegetable products contain more cadmium than 
animal products. Dietary exposure to cadmium from food sources is 
determined not only by cadmium levels in foods, but also by consumption 
patterns. Some of the food items that contain high cadmium levels are 
rarely consumed by the general European population (e.g. oilseeds and 
edible offal) and therefore might not be important for overall intake. Other 
food items with high consumption in the total population or in some sub-
populations can be major contributors to the overall cadmium intake even if 
they contain only low cadmium levels. 
 
 
1.5.7 Summary of different exposure pathways 
A source-pathway model for general cadmium flow is shown in Fig. 1 and 
a summary of different exposure sources of cadmium is presented in Table 
2. Oral exposure from food is clearly the dominating source of overall 
cadmium exposure for adult non-smokers with a small potential 
contribution from house dust in particularly contaminated areas. More 
highly contaminated individual foods can double total dietary exposure 
from a median of 2.27 in the mean diet up to a maximum of 4.64 μg/kg 
b.w. per week in simulated extreme diets. 
 20 
 
 
 
 
Fig. 1 Source-pathway model for general cadmium flow 
 
 
Some vegetarian diets seem to be able to almost triple the mean dietary 
cadmium exposure. In smokers, the contribution from smoking can 
increase overall cadmium exposure by 15- 30% when smoking between 20-
40 cigarettes a day. This does not take into account the higher pulmonary 
absorption compared to the gastrointestinal absorption. The potential 
contribution from different sources for a smoker living in an area with 
contaminated house dust is illustrated in Figure 2.The special scenario 
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calculated for children compared to the mean adult scenario showed that 
children are more exposed. 
 
 Source Pathway 
Range of calculated or 
reported exposures 
[μg/kg b.w. per week] 
Adults Children 
Dietary 
Exposure 
Food mean 
current opinion 
Oral 1.89-2.96 2.56-3.46 
Food high 
current opinion 
 2.54-3.91 5.49 
Food in 
industrial areas 
Oral 3.3-5.8 4.6 
Extreme diets 
current opinion 
Oral 2.87-4.64  
Vegetarians Oral 5.47  
Non-dietary 
exposure 
House dust Oral 0.076 0.607 
Air Inhalation 0.0024 0.0033 
Smoking Inhalation 0.35-0.70  
 
 
Table 2. Overview of mean weekly cadmium exposure estimates for the different 
exposure pathways. 
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Figure 2. Estimated relative contribution to cadmium exposure of different sources 
for adult smokers in the presence of contaminated house dust (A) and children in 
the presence of contaminated house dust (B). The small contribution from air is 
not visible. The contribution from smoking would increase if the internal dose is 
considered. 
 
A. Adult smokers
Smoking Dust Food Air
B. Children 0.5-12 years
Dust Food Air
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1.6 Cadmium: fate in body 
 
 
1.6.1 Absorption by route of exposure 
 
Cadmium may enter the body by ingestion, inhalation and, to a very limited 
extent, by passage through the skin. Although cadmium compounds are 
relatively poorly absorbed from the gastrointestinal tract (McLellan et al., 
1978), the occurrence of systemic toxicity following ingestion (Buckler et 
al., 1986) indicates that the absorption of cadmium from the 
gastrointestinal tract does occur and therefore that all cadmium compounds 
should be considered potentially harmful if ingested. During chronic 
background exposure, gastrointestinal absorption of cadmium is of the 
order of 2-8% (McLellan et al., 1978; Friberg & Elinder, 1983; Goyer, 
1986). It has been estimated that a European adult absorbs 1.4 - 8 µg of 
cadmium per day (Lauwerys, 1982). Physiological and nutritional factors 
may modify this: in people with low body stores of iron the absorption of 
cadmium may be significantly higher than in subjects with normal iron 
stores (Flanagan et al., 1978). Cadmium absorption tends to be higher in 
females than in males. The occurrence of fulminant acute pneumonitis and 
pulmonary oedema as well as neurotoxic effects following exposure to 
cadmium-containing dusts and fumes (see e.g. Beton et al., 1966; Barnhart 
& Rosenstock, 1984) indicates that inhalation of cadmium compounds 
must be considered serious and potentially fatal (Sittig, 1985; Lenga, 
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1988). Cadmium concentrations in ambient air are in the order of 0.001-
0.005 µg/m3 in rural areas, 0.003-0.05 µg/m3 in urban areas and up to 0.6 
µg/m3 near cadmium-emitting sources (Bernard & Lauwerys, 1986a). 
Much higher concentrations may occur in particular occupational 
environments. The rate of absorption of cadmium through the lungs is a 
function of the solubility and surface area of the inhaled particles. 20-30% 
of the inhaled cadmium is probably retained in the lungs. Therefore, the 
amount of cadmium retained in the respiratory tract would be 0.005-0.025 
µg in rural areas, 0.015-0.250 µg in urban areas and up to about 3 µg per  
day in areas near cadmium-emitting sources. Cigarette smoking adds 
considerably to cadmium intake. Friberg et al. (1974) estimated a daily 
intake of 2-4 µg of cadmium from the smoking of one packet of cigarettes 
per day.  Although dermal absorption of cadmium is not likely to be 
important, skin irritation may be caused by some cadmium compounds 
(Sittig, 1985; Lenga, 1988). Exposure to many cadmium compounds as 
well as cadmium dusts and fumes is likely to produce severe corrosive 
damages to the eye (Lenga, 1988).  
 
1.6.2 Transport 
 
In the blood, cadmium is mainly found in the erythrocytes, where it is 
mainly bound to metallothionein (MT), a low-molecular weight protein that 
strongly binds cadmium on its cysteine (sulfur SH) rich groups (Nordberg 
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et al., 1971a). Cadmium may also bind to other SH-rich low-molecular 
weight peptides or amino acids such as glutathione and cysteine 
respectively (Zalups and Ahmad, 2003). MT is also present in blood 
plasma and serves as the main transport for cadmium into the kidneys 
because of its low molecular weight (Nordberg and Nordberg, 2000). MTs 
are small, cysteine rich metal binding proteins which participate in an array 
of protective stress responses (Lehman-McKeeman and Klaassen, 1987). 
They likely evolved as a mechanism to regulate zinc levels and distribution 
within cells. Seven zinc atoms are shared between two clusters (with 3 and 
4 binding sites) of the MT monomer, but cadmium can substitute zinc in 
both clusters. The small size of MT enables the protein to be filtered 
through the kidney glomerular membrane. It is then reabsorbed into 
proximal tubular cells (Nordberg et al., 1971b; Foulkes, 1978). Cadmium 
exposure induces the synthesis of MTs in several tissues (Nordberg et al., 
1985). Cd-MT has a longer half-life in vivo than Zn-MT. Early work 
indicated that MT binding decreased the toxicity of cadmium, and the 
ability of the liver to synthesise MT appeared to be adequate to bind all the 
accumulated cadmium (Nordberg et al., 1971b; Kotsonis and Klaassen, 
1978). Cadmium-induced nephrotoxicity is probably due to unbound 
cadmium as the ultimate toxicant (Nomiyama and Nomiyama, 1986), as 
shown in Figure 3. The route of cadmium administration does not appear to 
affect the MT metabolism in liver and kidney, though inhalation induces 
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lung MT (Glaser et al., 1986; Hart, 1986) and oral exposure induces 
intestinal MT (Muller et al., 1986). A schematic presentation of cadmium 
metabolism and nephrotoxicity is illustrated in figure 3. Cadmium bound to 
albumin is to a large extent taken up by the liver where the complex is split 
and only minute amounts reach the kidney proximal tubuli (step l in figure 
3). In liver cells, cadmium induces the synthesis of metallothionein (MT). 
Cadmium is then excreted in bile mainly bound to glutathione (GSH). 
Redistribution occurs from the liver. Cadmium is either excreted in bile 
mainly bound to glutathione (GSH), or released into the plasma as Cd-MT. 
The complex Cd-MT is filtered through the renal glomeruli and then 
reabsorbed by proximal tubular cells until the critical concentration is 
reached. The critical concentration is represented by the cadmium burden at 
which tubular cells are no longer able to synthesise enough MT to 
neutralise free Cd2+ produced by lysosomal degradation of Cd-MT. When 
the critical concentration is exceeded, tubular damage results in increased 
enzymuria, low molecular weight proteinuria, and increased excretion of 
cadmium either as Cd-MT or, probably, also as Cd2+. 
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Figure 3. Cadmium metabolism and nephrotoxicity. Upon chronic exposure, 
cadmium nephrotoxicity depends on the imbalance between the liver ability to 
synthesise MT carrying cadmium to the kidney and the ability of the latter to 
synthesise the renal counterpart of MT necessary to neutralise Cd2+ delivered 
from lysosomal degradation of the Cd-MT complex. 
 
 
 
 
1.6.3 Distribution 
 
Distribution of cadmium in animals after oral exposure shows the highest 
accumulation in the liver and kidneys (Kotsonis and Klaassen, 1978). Liver 
and kidney cadmium concentrations are comparable after short-term 
exposure (Andersen et al., 1988), but the kidney concentration exceeds the 
liver concentration following prolonged exposure, except at very high 
exposures (Bernard et al., 1990). Zinc and calcium deficiencies may also 
result in an increased accumulation of cadmium in the intestinal wall, liver 
and kidney (Foulkes and Voner, 1981; Reeves and Chaney, 2008). Non-
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occupationally exposed people are exposed to cadmium primarily through 
the diet and either active or passive tobacco smoke. Cadmium can be 
detected in virtually all tissues in adults from industrialised countries, with 
the greatest concentrations in the liver and kidney (Sumino et al., 1975; 
Chung et al., 1986). Average cadmium concentrations in the kidney are 
near zero at birth, and rise almost linearly with age to a peak (typically 
around 40-50 mg/kg wet weight) between ages 50 and 60, after which 
kidney concentrations decline. Liver cadmium levels also begin near zero 
at birth, increase to typical values of l-2 mg/kg wet weight by age 20-25, 
then increase only slightly (Sumino et al., 1975; Lauwerys et al., 1984; 
Chung et al., 1986). In humans subjected to normal low-level exposures, 
approximately 50% of the total cadmium body burden at autopsy is found 
in the kidney and 15 % in the liver, and only a relatively small part is stored 
in bone (Christoffersen et al., 1988; Nordberg et al., 2007). In several 
studies, including both smoking and non-smoking women, the cadmium 
concentration was approximately half as high in cord blood as in maternal 
blood (Lauwerys et al., 1978; Kuhnert et al., 1982; Truska et al., 1989). 
Accumulation of cadmium in the placenta at levels about 10 times higher 
than maternal blood cadmium concentration has been observed in studies 
of women in Europe, e. g. (Roels et al., 1978) and the United States 
(Kuhnert et al., 1982). The thyroid, the pancreas and the salivary glands 
also accumulate significant amounts of cadmium.  
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1.6.4 Metabolism 
 
There is no evidence that the divalent cadmium cation undergoes 
biotransformation in man. 
 
1.6.5 Excretion 
 
Most of the inhaled cadmium that is transported to the gut via mucociliary 
clearance is not absorbed from the gastrointestinal tract (Moore et al., 
1973; Rusch et al., 1986). Absorbed cadmium is excreted very slowly, with 
urinary and faecal excretion being approximately equal. The amount 
excreted daily represents only about 0.007-0.009% of the total body burden 
(Kjellström and Nordberg, 1978; Nordberg et al., 1985). Low excretion 
rates of cadmium lead to efficient retention in the body. The biological 
half-time in kidneys was estimated to be 12-20 years (Elinder et al., 1976; 
Kjellström & Nordberg, 1978; Roels et al., 1981) and that in the liver 
somewhat shorter (Kjellström & Nordberg, 1978). 
 
 
1.7 Cadmium: toxicity 
 
 
1.7.1 History 
 
The earliest observations of toxic effects from cadmium exposure are from 
clinical medicine. Sovet (1858) reported on acute gastrointestinal 
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symptoms as well as delayed respiratory symptoms among persons using 
cadmium carbonate powder as a polishing agent causing both inhalation 
and oral intake of this cadmium compound. Early toxicological 
contributions were those by Alsberg and Schwartze (1919) and by 
Schwartze and Alsberg (1923) on the pharmacology of cadmium. They 
were based on animal experiments and reported various clinical signs and 
morphological changes in organs of a variety of vertebrates including birds 
and dogs. Acute gastrointestinal effects with vomiting and diarrhea in 
persons consuming Cd contaminated food and drink were reported in the 
1940's (US Publ Health Serv, 1942). Nicaud et al. (1942) observed a 
systemic effect, osteomalacia, in a few Cd-workers. Friberg (1948) 
presented the first report on the characteristic combination of proteinuria 
and emphysema in chronic cadmium poisoning occurring among Cd 
workers. Itai-itai disease (Japanese for Ouch-Ouch disease) is a bone 
disease with fractures and severe pain that occurred after World War II in 
Fuchu, Toyama prefecture, Japan (Hagino, 1957) (figure 4).  
Dr. Hagino was a local practitioner who initiated studies concerning this 
disease. X-ray findings included Milkman's pseudofractures (Looser´s 
zones) in the long bones, changes characteristic of osteomalacia. There 
were also decalcification and fractures of other bones including 
compression fractures of the spine. In the area where the disease occurred,        
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women had the habit of screening out sunlight by wearing typical dress 
with wide hats, thus limiting dermal synthesis of active vitamin D. 
 
 
 
 
 
 
 
 
 
Figure 4. Itai-Itai disease induced by long-term Cadmium-exposure. 
 
Biochemical findings were characteristic of osteomalacia with increased 
serum levels of alkaline phosphatase and decreases in calcium and 
phosphate. Anemia and gastrointestinal and renal dysfunction were other 
less prominent findings [Ishizaki, 1969, Murata et al., 1970]. In these cases, 
elevated levels of Cd in urine were found [Ishizaki, 1969] and in 1968 the 
disease was declared by the Japanese Government to be a disease related to 
environmental pollution. Cadmium, released from a mine in the mountains 
was transported by the Jinzu River into the plain, where the contaminated 
water was used for irrigation of rice fields (figure 5). The rice plant takes 
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up Cd from the soil and consumption of contaminated rice is the main route 
of exposure for the general population.  
 
Figure 5. Acid mine drainage of heavy metals including cadmium, lead, 
andarsenic threatens waterways with toxic contamination. 
 
. 
 
1.7.2 Health effects 
1.7.2.1 Kidney 
 
 
There is now a consensus among scientists to say that in chronic Cd 
poisoning the kidney, which is the main storage organ of Cd, is also the 
critical target organ, i.e. the first organ to display signs of toxicity 
[Berbard A., 2008]. The earliest manifestation of Cd-induced renal 
damage considered as critical consists in an increased urinary excretion 
of microproteins (molecular weight <40 kD). Among these proteins, 
β2-microglobulin, retinol-binding protein and alpha1-microglobulin 
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have been the most validated for the routine screening of tubular 
proteinuria. The increased loss of these proteins in urine is a reflection 
of the decreased tubular reabsorption capacity. A modest increase in 
the urinary excretion of these proteins, as found at the early stage of Cd 
nephropathy, is unlikely to compromise the renal function [Berbard A., 
2008]. Such a small increase might even be reversible after removal 
from Cd exposure. By contrast, when the urinary excretion of these 
proteins is increased by more than one order of magnitude, tubular 
dysfunction caused by Cd becomes irreversible and may be associated 
with a lower glomerular filtration rate (GFR) and an accelerated 
decline of the GFR with ageing [Bernard A., 2008]. The disturbances 
of calcium and phosphate metabolism accompanying Cd nephropathy 
may lead to bone demineralization, the formation of kidney stones and 
bone fractures. Prospective studies among inhabitants living in Cd-
polluted areas in Japan have shown that the development of Cd-
induced proteinuria is predictive of an increased mortality by heart 
failure, cerebral infarction, nephritis and nephrosis14. There is some 
epidemiological evidence that diabetics are more susceptible to the 
nephrotoxic action of Cd, a finding consistent with animal studies 
[Bernard A., 2008]. 
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1.7.2.2 Bone 
 
Although first reported in French workers by Nicaud et al. [1942], toxic 
effects of Cd on the bones really became evident with the outbreak of 
the Itai-Itai disease in the Cd-polluted area of Toyama, Japan, after 
World War II. Itai-Itai disease patients presented, indeed, a severe 
osteomalacia accompanied with multiple bone fractures and renal 
dysfunction9. They complained of pain in the back and in the 
extremities, difficulties in walking and pain on bone pressure (hence 
the name Itai-Itai meaning Ouch-Ouch in Japanese). Recent studies in 
China have confirmed the bone toxicity of Cd. Nordberg et al. [2002] 
have found decreased bone mineral density in Chinese farmers exposed 
to Cd from contaminated rice for more than 20 yr. The bone mass 
density was decreased in postmenopausal women with elevated Cd in 
urine or blood as well as among men with elevated Cd in blood. Bone 
lesions have been regarded for long as late manifestations of 
intoxication, occurring only after relatively high exposures in the 
industry or environment. Effects on the bone, especially at high 
exposure, are largely the consequence of Cd nephropathy, resulting in 
an altered vitamin D metabolism and a urinary waste of calcium and 
phosphate.  
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1.7.2.3 Others (respiratory system, liver, cardiovascular system , 
reproductive system and embryo, central nervous system, retina) 
 
 
Depending on the dose, route and duration of exposure, Cd can damage 
various other organs and systems including lung, liver, cardiovascular 
and reproductive systems, embryo, placenta, central nervous system 
and retina. With regard to the respiratory system, experimental studies 
have shown that cadmium-containing aerosols induce destruction of 
Type I epithelial cells with pulmonary oedema, followed by a 
reparative process. The earliest stages of Cd-induced lung injury 
primarily involve the disruption of the alveolar septum and the leakage 
of fluid and solutes into the alveoli [Prozialeck W.C., 2006]. However, 
these early stages of injury are soon followed by the influx and 
activation of leukocytes and the release of inflammatory mediators that 
facilitate the inflammatory processes responsible for subsequent 
pulmonary injury and fibrosis [Prozialeck W.C., 2006]. 
With low level oral or respiratory exposure, liver is the first site where 
Cd is  initially distributed; it can bind to glutathione and/or induce the 
synthesis of the Cd-binding protein metallothionein, which are both 
thought to serve as intracellular lines of defense against Cd toxicity 
[Prozialeck W.C., 2006]. Under these conditions, the liver is usually 
not injured. By contrast, with the acute, higher levels of exposure that 
are often used in animal studies, the liver rapidly accumulates high 
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levels of Cd that overcome these defense mechanisms and the liver 
becomes one of the primary sites of injury. Under these conditions, 
changes in hepatic vascular endothelial cells are evident after as little as 
2–3 h of exposure, and signs of parenchymal necrosis and/or apoptosis 
develop several hours later [Prozialeck W.C., 2006].With regard to the 
cardiovascular system, exposure to Cd has been associated with a wide 
variety of cardiovascular pathologies including hemorrhagic injury, 
atherosclerosis, hypertension and cardiomyopathy [Prozialeck W.C., 
2006]. Cadmium may also cause severe damage to embryos and the 
reproductive organs in adults including the ovary and testes, which are 
sensitive to Cd toxicity (for an extensive review, see Thompson and 
Bannigan, 2008 “Cadmium: Toxic effects on the reproductive system 
and the embryo”). The toxic effects of Cd in the central nervous system 
(CNS) are still poorly understood. As a matter of fact the anatomical 
structure of the blood brain barrier (BBB) in the newborn and in the 
adult is analogue; nevertheless it has been widely demonstrated that 
BBB in the newborn has different functional characteristic. Cd, such as 
other compounds, could pass the BBB exploiting the natural 
transporters of the essentials metals (Bressler et a., 2007). Furthermore 
some papers hypothesized that several diseases including Parkinson 
disease (Dhillon et al., 2008), as well as malformations (Paniagua-
Castro et al., 2008) such as spina bifida (Kalter, 1985) and forelimb 
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ectrodactyly (Schreiner et al., 2009) might be related to Cd exposure. 
Concerning the role of Cd in the etiopathogenesis of sporadic and 
familiar amyotrophic lateral sclerosis (ALS), some data identify it as a 
candidate risk factor (Huang et al., 2006; Bar-Sela et al., 2001; Vinceti 
et al., 1997); nevertheless more studies are needed to provide a 
definitive answer concerning the cause-effect relationship between Cd 
and ALS. Moreover several studies indicate that children of women 
exposed to Cd during pregnancy show lower motor and perceptual 
abilities, and that high Cd body burden in children is also related to 
impaired intelligence, lowered school achievement and nonadaptive 
classroom behavior (Thatcher et al., 1982; Bonithon-Kopp et al., 1986). 
The distribution and deleterious effects of Cd in retinal tissues have not 
yet been extensively studied. Dysfunction of the retinal pigment 
epithelium (RPE) underlies numerous retinal diseases and has been 
implicated in age-related macular degeneration (AMD), a leading cause 
of blindness. Recently, Erie et al. (2005) demonstrated that cadmium is 
present in the retinal pigment epithelium/choroid at levels higher than 
in the blood or ocular fluids and that cadmium levels in the retinal 
tissues were approximately double in smokers compared to 
nonsmokers. In addition, higher urinary cadmium levels, indicating a 
higher total body burden of cadmium, were found in smokers who had 
AMD compared to smokers who did not have AMD [Erie et al., 2007]. 
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These findings raised the possibility that cadmium exposure might play 
a role in tobacco-related AMD. Moreover, rececently, it was 
demonstrated that human retinal tissues accumulate Cd during aging 
[Wills et al., 2008]. Among its numerous cellular toxic effects, 
cadmium is a potent inflammatory agent and increases oxidative stress. 
Oxidative stress and inflammation have both been linked to AMD 
[Hollyfield et al., 2008]. Gender might also influence cadmium 
absorption. Satarug et al. (2004) reported that women who were non-
smokers had nearly the same cadmium body burden as men who 
smoked an average of nine cigarettes per day for nearly 10 years.  
 
1.7.2.4 Cadmium and cancer 
 
International Agency for Research on Cancer (IARC,1993) classified 
cadmium as a human carcinogen (group I) on the basis of sufficient 
evidence for carcinogenicity in both humans and experimental animals, 
while the European Commission has classified some cadmium 
compounds as possibly carcinogenic (Carcinogen Category 2; Annex 1 
to the Directive 67/548/EEC). IARC's evaluation was largely based on 
studies on occupationally exposed workers, but study populations were 
rather small, data on historical exposure to cadmium were sparse and 
concomitant exposure may have confounded the results as noted in 
subsequent studies [Järup et al., 2009]. Strong evidence, based on 
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experimental studies, exists to support the carcinogenic potential of Cd. 
Cell transformation, a routinely employed diagnostic in vitro test for 
the carcinogenic potential of chemicals, has been employed in several 
studies not only to demonstrate the carcinogenic potential of Cd but 
also to gain insight regarding the mechanisms potentially underlying 
Cd carcinogenesis [Järup et al., 2009]. Following various routes of 
exposure to Cd, experimental animals produce tumors of multiple 
organs. In addition, injection of Cd containing compounds in animals 
resulted in local tumors, typically sarcomas, at the site of injections. 
Epidemiological evidence is also available to document the 
carcinogenic potential of Cd. Although, the evidence is not very strong, 
cancers of the prostate, kidney, and pancreas have been reported in 
populations who are exposed to Cd [Järup et al., 2009]. It is, however, 
worth mentioning that, like any other epidemiological study, the results 
of studies involving Cd carcinogenesis should be interpreted with 
caution primarily because of confounding factors such as coexposure to 
other toxic chemicals and life style factors, for example, cigarette 
smoking. Despite such limitations, a causal relationship has been 
observed between Cd exposure and the occurrence of lung cancer in 
human and the administration of compounds containing Cd have 
resulted in tumors of multiple organs/tissues in experimental animals 
prompting the International Agency for Research on Cancer (IARC) to 
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finally classify Cd as a human carcinogen in 1993 [IARC, 1993]. More 
recently, cadmium was proposed as a potent metalloestrogen [Järup et 
al., 2009]. The metal was shown to increase estrogen receptor alpha-
mediated cell proliferation [Järup et al., 2009].; and to possess 
mutagenic properties . Although some in vitro estrogenicity assays 
showed no activity, environmentally relevant doses of cadmium 
induced several well-characterized estrogenic responses in vivo, 
including increased uterine weight, hyperplasia and hypertrophy of the 
endometrial lining, induction of uterine progesterone receptor and 
complement C3 gene expression in animals [Järup et al., 2009]. In 
addition, after in utero exposure, cadmium affected mammary gland 
development and early onset of puberty in female offspring — both 
prototypical endocrine disruptor-like responses [Järup et al., 2009]. 
Furthermore a possible effect of cadmium on breast cancer risk was 
assessed in a case–control study. Women in the highest quartile of 
creatinine adjusted urinary cadmium levels had twice the breast cancer 
risk of those in the lowest quartile after adjustment for established risk 
factors, and there was a statistically significant increase in risk with 
increasing cadmium level [Järup et al., 2009]. Increased cadmium 
concentrations in breast adipose tissue samples from breast cancer 
patients, and a suggestive correlation of cadmium with estrogen 
receptor levels has been also demonstrated [Järup et al., 2009].. 
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1.7.3 Molecular aspects 
 
1.7.3.1 Inhibition of DNA repair 
 
 
Cadmium is not directly genotoxic, it is non-mutagenic in bacteria and 
weakly mutagenic in mammalian cells with contrasting evidence. Two 
mechanisms play an important role in cadmium genotoxicity: 1) 
induction of reactive oxygen species (ROS) and 2) inhibition of DNA 
repair. At high cytotoxic doses cadmium induces DNA single-strand 
breaks and genome instability in several types of mammalian cells 
likely due to oxidative stress. At sub-cytotoxic concentrations cadmium 
is also harmful because it can sensitize cells to external agents by 
inhibiting DNA repair. By this mechanism cadmium can enhance the 
mutagenicity induced by other DNA damaging agents. The precise 
molecular mechanism involved in the inhibition of DNA repair by 
cadmium has not been clearly identified. Cadmium does not directly 
modify DNA but its capacity to inhibit DNA repair enzymes may 
contribute to its genotoxic effects. 
 
1.7.3.2 Effects on gene expression 
 
 
Cadmium affects both gene transcription and translation. Cadmium 
regulates the internal cell concentration of calcium and plays the role of 
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an alternative signalling molecule controlling various transduction 
pathways. Moreover, cadmium may interfere with calcium homeostasis 
by its ability to modulate extracellular calcium sensing receptors 
(CaSR). In this way cadmium may profoundly affect the function of 
cells expressing CaSR such as kidney cells that are involved in calcium 
homeostasis. A recent study on mice showed that cadmium introduced 
morphological changes and reduced the level of calcium in the 
mammary gland and decreased beta-casein gene expression, suggesting 
that cadmium can disturb the function of the lactating mammary gland, 
which may impair the development of the suckling offspring. Cadmium 
is not a redox-active metal and cannot itself direct Fenton type-
reactions but it induces the production of ROS by indirect processes, a 
decrease of cellular antioxidants and exhalation of ROS by 
mitochondria. Cadmium by perturbing the redox homeostasis impacts a 
large set of transcription factors characterized by reactive cysteines. 
Among these, MTF1 which is the inducer of MT. Moreover, by 
inducing oxidative modification of proteins cadmium can also target 
these proteins to degradation. By modulation of gene expression and 
signal transduction cadmium may affect cell proliferation, 
differentiation, apoptosis and other cellular activities. The perturbation 
of these processes may all contribute to carcinogenicity. 
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1.7.3.3 Endocrine functions 
 
 
The concomitant manifestations of proximal renal tubular dysfunction 
and anaemia with erythropoietin (Epo) deficiency observed in chronic 
cadmium intoxication, such as Itai-itai disease, suggest a close local 
correlation between the cadmium-targeted tubular cells and Epo-
producing cells in the kidney. Recent studies show that cadmium has a 
strong inhibitory effect on Epo expression both in vitro and in vivo. It is 
well known that moderate to high dose exposure to cadmium (1 mg/kg 
for 5 days/week for 6 weeks by i.p.) affects steroid synthesis in 
reproductive organs in female rats. It has been shown that low dose 
cadmium exposure has potent oestrogen- and androgen-like activities 
in vivo and in vitro, by directly binding to oestrogen and androgen 
receptors. Cadmium, like oestradiol, can cause rapid activation of 
ERK1/2 and AKT. However, the precise mechanisms underlying the 
effects of cadmium as an endocrine disruptor remain to be elucidated. 
 
 
 
1.8 Notes 
 
Product recalls. In May 2006, a sale of the seats from Arsenal F.C.'s old 
stadium, Highbury in London, England was cancelled after the seats were 
discovered to contain trace amounts of Cadmium [6]. Reports of high 
levels of cadmium use in children's jewelry in 2010 led to a US Consumer 
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Product Safety Commission investigation. Twelve percent of the 103 items 
tested from New York, Ohio, Texas and California contained at least 10 
percent cadmium, with a single item test claimed to be 91 percent cadmium 
[7]. The CPSC issued specific recall notices for cadmium content applying 
to jewelry sold by Claire's [8] and Wal-Mart [9] stores. In June 2010 
McDonald's voluntarily recalled more than 12 million promotional “Shrek 
Forever After 3D” Collectable Drinking Glasses due to concerns over 
cadmium levels in paint pigments used on the glassware [Neuman, 2010]. 
The glasses were manufactured by ARC International, of Millville, NJ, 
USA [10]. 
 
1.9 Aim of the study 
 
Even though Cd represents a major environmental health problem, the 
specific mechanisms by which it produces its adverse effects have yet to be 
fully elucidated. Studies to address this issue have shown that Cd can cause 
a variety of biochemical, metabolic and cytotoxic effects. However, in most 
cases, the relationships between these effects and the specific toxic actions 
of Cd in various target cells, tissues and organs have not been firmly 
established. 
This study focused on the role of cadmium on human cells, tissues and 
organs with special attention to morphology, cell proliferation, apoptosis, 
 45 
differentiation-related gene expression, and angiogenic potential. This 
research project was subsidized by the Italian National Institute of Health 
(Istituto Superiore di Sanità – ISS) and the University of Florence (Italy); 
in particular, our scientific group belonged to the Strategic Project “The 
gender medicine as a strategic target for public healt: the suitability of the 
cure for the care of woman health”, Project 3: “Endocrin interferents in 
occupational environments and woman healt” (Progetto strategico: “La 
Medicina di genere come obiettivo strategico per la sanità pubblica: 
l'appropriatezza della cura per la tutela della salute della donna”,  Progetto 
3: “Interferenti endocrini negli ambienti di lavoro e salute della donna”). 
For that reason our study focused principally on the biological effects of 
cadmium on cells, tissues and organs involved in female and foetus health. 
Hence experimental models adopted were: normal and tumour human 
breast cell lines (MCF-7 and MCF-10A respectively), primary human 
neuroblast cell line from foetal olfactory neuroepithelium (FNC-B4), 
explants of human foetal spinal cord, and, more recently, primary human 
neurons from foetal basal nuclei and primary (murine) retinal ganglion 
neurons. 
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2 MATERIALS AND METHODS 
 
 
2.1 Cadmium and normal/tumour human breast cell lines (MCF-7 
and MCF-10A respectively) 
 
 
MCF-7 (acronym of Michigan Cancer Foundation - 7, referring to the 
institute in Detroit where the cell line was established in 1973) is a human 
breast adenocarcinoma cell line isolated in 1970 from a 69-year-old 
Caucasian woman. MCF-7 cells are useful for in vitro breast cancer studies 
because the cell line has retained several ideal characteristics particular to 
the differentiated mammary epithelium. These include the ability for MCF-
7 cells to process estrogen, in the form of estradiol, via estrogen receptors 
in the cell cytoplasm. This makes the MCF-7 cell line an estrogen receptor 
(ER) positive control cell line. 
The MCF 10A cell line is a non-tumorigenic epithelial cell line. 
These cells were derived from the mammary tissue of a cystic fibrosis 
patient and have normal mammary epithelial cell morphology. The line was 
produced by long term culture in serum free medium with low Ca++ 
concentration. MCF 10A was derived from adherent cells in the population. 
Similar to normal human breast epithelial cells, at confluence the MCF-
10A cells form dome structures in tissue culture plates; in addition they 
have shown no signs of terminal differentiation or senescence. MCF-10A 
cells are frequently used as a normal control in breast cancer studies.  
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2.1.1 Cell culture and treatments 
 
The MCF-7 and MCF-10A cell lines were obtained from American Type 
Culture Collection (ATCC, Rockville, MD, USA). 
MCF-7 were cultured in Eagle's MEM, supplemented with 10% FBS, 1% 
penicillin/streptomycin, insulin (10ug/mL) and sodium pyruvate (1mM). 
MCF-10A were cultured in Ham’s F-12 medium and DMEM (1:1) 
supplemented with 5% FBS, 1% penicillin/streptomycin, insulin 
(10ug/mL), EGF (20ng/mL), cholera enterotoxin (100 ng/mL), 
hydrocortisol (0.5 mg/mL). 
Materials for cell culture are bought from Invitrogen Co., Carlsbad, CA, 
USA. 
Both MCF-7 and MCF-10A were switched, 24 h before the treatments, 
from complete culture medium to DMEM serum-free medium; then, at the 
beginning of each experiment, the medium was replaced with DMEM 
without phenol red and serum-free medium containing different 
concentrations of cadmium chloride (CdCl2; Sigma-Aldrich, St. Louis, 
MO, USA). Treatments with and without  CdCl2 are carried out for 48 h. 
 
2.1.2 Histological staining and morphologic analysis 
 
For the study of cell morphology, both the cell lines were cultured on cover 
slips placed inside 6 multi-well culture plates, in serum-free medium for 24 
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h and then incubated with 1, 10 and 100 μM, and 1 mM CdCl2 for 48 h. 
After the exposure the cover slips were air dried and then fixed with Citofix 
(BD Biosciences, MA, USA). Successively the specimens were stained 
using the Papanicolaou method: briefly each specimen was hydrated in 
descending concentrations of 95% alcohol through 50% alcohol to distilled 
water for 2 min in each stage, then it was treated with Harris' Haematoxylin 
for 5 min, to stain the nuclei, rinsed in distilled water and differentiated in 
0.5% aqueous hydrochloric acid (0,5% in 70% alcohol) for 1 minute to 
remove the excess stain. The specimen then was immediately rinsed in 
distilled water to stop the action of discoloration. For cytoplasmic staining 
each specimen was then dehydrated in ascending alcoholic concentrations 
from 70% through two changes of 80% alcohol for 2 min for each change 
and then treated with Papanicolaou Orange G6 for 5 min, rinsed in 90% 
alcohol (three changes for 1 minute for each change) and treated with eosin 
Azure 50 for 5 min. Each specimen was dehydrated in alcoholic 
concentrations from three changes of to 99% alcohol for 1 minute for each 
change. Finally the specimens were cleared in Xylene and mounted on 
microscope glass slides with Canada balsam. All reagents used were from 
Sigma Diagnostics, St. Louis, MO, USA. Specimens were then examined 
with an optical microscope (Nikon Instruments S.p.A., Milan, Italy) at 
different magnifications and images were acquired. 
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2.1.3 Cell proliferation 
 
Cell proliferation was evaluated by Bromodeoxyuridine (BrdU) Cell 
Proliferation Assay (Calbiochem, San Diego, CA, USA).  
Cells were seeded in complete medium at a density of 1x105 in 96 multi-
well culture dishes; then, after starvation, the medium was replaced by 
phenol red and serum-free medium containing different concentrations of 
CdCl2. Treatments with and without  CdCl2 were carried out for 48 h. 
After 30 h from the CdCl2 exposure the BrdU solution was added to each 
specimen and the following procedure steps were performed according to 
the manufacturer's instruction. Absorbance in each well was measured 
using a Victor3 Multilabel Reader (Perkin Elmer, Boston, MA, USA) at 
wavelength of 450 nm. 
 
2.1.4 SDS-PAGE, western blotting analysis, and immunoblotting 
 
Cells were seeded in complete medium in 6 multi-well culture dishes; then, 
after starvation, the medium was replaced by phenol red and serum-free 
medium containing different concentrations of CdCl2. Treatments with and 
without  CdCl2 were carried out for 48 h. 
For VEGF, full length and cleaved PARP analysis, cells were homogenized 
in an ice-cold lysis buffer (50 mM Tris HCl, pH 7.5, 150 mM NaCl, 1 mM 
EDTA, 1% Triton, 0.25% sodium dodecyl sulfate) supplemented with a 
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protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA) and 
centrifuged for 15 min at 4°C at 10,000 g. The supernatant was collected 
and protein concentration was measured using a Coomassie Bio-Rad 
protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA). Aliquots 
containing 20 μg of proteins were diluted in a 4X reducing Laemmli’s 
sample buffer (250 mM Tris-HCl, pH 6.8, 20% glycerol, 8% SDS, 20% 2-
mercaptoethanol, 0,008% bromophenol blue) and loaded into 10% SDS-
PAGE. Then, proteins were transferred on polyvinylidene difluoride 
membranes (Hybond-P; Amersham Bioscience, Piscataway, NJ, USA). 
Membranes were blocked for 1 h at room temperature in 5% BSA-TTBS 
buffer (0.1% Tween 20, 20 mM Tris-HCl, 150 mM NaCl, pH 7,5), washed 
in TTBS, and incubated at 4°C overnight with primary antibodies: anti-
VEGF, 1:2000 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-
PARP, 1:2000 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Primary 
antibodies were diluted in TTBS and incubations were followed by 
peroxidase-conjugated secondary IgG treatment (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA). Finally, the reacted proteins were 
revealed by the enhanced chemiluminescence system (ECL plus, 
Amersham Bioscience, Piscataway,  NJ, USA). Image acquisition and 
densitometric analysis were performed with Quantity One software on a 
ChemiDoc XRS instrument (Bio-Rad Laboratories Inc.). 
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2.1.5 Angiogenesis (chicken embryo chorioallantoic membrane -CAM- 
assay) 
 
Fertilized White Leghorn chicken eggs were incubated under routine 
conditions and a square window was opened in the egg shell at day 3 of 
incubation. Gelatin sponges (1 mm3) were placed on the top of the CAM at 
day 8. The sponges were then absorbed with 5 µl of compounds to be 
tested. Sponges containing PBS were used as negative controls; 
prostaglandin E1 (PGE1) was used as stimulator of angiogenesis. MCF-7 
and MCF-10A cells, untreated and treated with different concentrations of 
CdCl2 for 48 h, were used at a concentration 50.000 cells/sponge. In each 
experiment we used six eggs per experimental point (i.e. six eggs treated 
with PBS, six eggs treated with PGE1, and so on). Each experiment was 
repeated three times. Thus, the reported results refer to a total of 18 eggs 
per experimental point. Eggs were examined by microscopy, and positive 
angiogenesis was considered if new microvessels (in particular, 
microvessels surrounding the sponge, defined as circumfocal 
microvessels) had developed. Captured images were digitized and 
analysed for number of angiogenic blood vessels (i.e. those surrounding 
the sponges), using a customized image analysis software program (Scion 
Corporation, USA). Small (< 1 mm dia.), large (> 1 mm dia.), and tortuous 
microvessels were observed at the magnification x5. Angiogenesis was 
assessed by scoring the circumfocal microvessel number (CFMN). 
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Observers (two for each experiment), were blinded for what concerned the 
experimental conditions. 
 
 
2.2 Cadmium and primary human neuroblast cell line FNC-B4 
 
 
The primary human neuroblast long-term cell line FNC-B4 has been 
established, cloned, and propagated in vitro from human fetal olfactory 
epithelium [Vannelli et al., 1995]. FNC-B4 cells synthesize both neuronal  
proteins and olfactory markers and respond to odorant stimuli, suggesting 
their origin from the stem cell compartment that generates mature olfactory 
receptor neurons. Moreover, this system represents a model of 
neurogenesis that, simplifying the cellular heterogeneity of the developing 
nervous system, may help in investigating in vitro pathologic perturbations 
of the activation, self renewal, differentiation, and survival of primary 
neuronal precursors. Thus, FNC-B4 cells represent a human in vitro model 
that can be useful in providing additional information on the effects of 
cadmium in neurons.  
 
2.2.1 Cell culture and treatments 
 
The primary human neuroblast long-term cell line FNC-B4 was isolated, 
cloned and propagated in vitro from human fetal olfactory neuroepithelium, 
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as described in Vannelli et al., 1995. These cells express neuronal 
stem/differentiation markers indicating that they originate from the 
neuroblastic precursor compartment, which gives rise to mature neurons 
throughout life. FNC-B4 cells express olfactory specific markers: Olfactory 
Marker Protein (OMP; it is a phylogenetically conserved protein; its 
function has remained largely elusive); olfactory-type G protein (Golf; it 
activates the lyase adenylate cyclase which converts ATP in cyclic AMP); 
Olfactory Cyclic Nucleotide-gated Channel (OCNC; it is a channel 
activated by binding of cAMP and conducting a depolarizing receptor 
current that leads to electrical excitation of the neuron); Olf-1 (an olfactory 
neuron-specific trans-acting factor capable of interacting with some 
olfactory neuron-specific genes). FNC-B4 were cultured in Coon’s 
modification of F12 medium, supplemented with 10% foetal bovine serum 
and antibiotics. Materials for cell culture were bought from Invitrogen Co., 
Carlsbad, CA, USA. The FNC-B4 cell line grows as a monolayer, is non-
tumorigenic and has a normal human kariotype. Cryogenically preserved, 
early passages of FNC-B4 cells are used in the present study. 
FNC-B4 were switched, 24 h before the treatments, from complete culture 
medium to Coon’s modification of F12 serum-free medium; then, at the 
beginning of each experiment, the medium was replaced with a Coon’s 
modification of F12 serum-free medium containing 10 and 100 μM 
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cadmium chloride (CdCl2; Sigma-Aldrich, St. Louis, MO, USA). 
Treatments with and without  CdCl2 are carried out for 24 h. 
 
2.2.2 Phase-contrast light microscopy 
 
For contrast phase microscopic observation, FNC-B4 cells were cultured 
on Petri dishes in serum-free medium for 24 h and then sham exposed or 
incubated with 10 and 100 μM CdCl2. Cells were then viewed with a 
Nikon Microphot-FX microscope (Nikon Instruments S.p.A., Milan, Italy) 
at the original magnfication of x40. 
 
2.2.3 Immunohistochemistry and confocal laser scanning microscopy 
 
 
FNC-B4 cells were cultured on slides in the appropriate medium and then 
they were fixed with 3.7% paraformaldehyde (pH 7.4) for 10 min and 
permeabilized for 10 min with PBS containing 0.1% Triton X-100 (Sigma- 
Aldrich, St. Louis, MO, USA). After rinsing in PBS, the slides were 
incubated with 2% bovine serum albumin for 15 min. Immunostaining was 
performed using the following primary antibodies (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA, USA): vimentin antibody (V9; 
dilution 1:100; incubation overnight at 4°C);  β-Tubulin III antibody (TU-
20; dilution 1:100; incubation overnight at 4°C) and GFAP antibody (H-50; 
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dilution 1:500; incubation overnight at 4°C). Then, incubations with 
appropriate secondary conjugated antibodies were performed: A-11001 
Alexa Fluor 488 goat anti-mouse IgG conjugated antibody (Invitrogen Co., 
Carlsbad, CA, USA) (dilution 1:200; incubation for 60 min at room 
temperature) for the detection of vimentin; R6393 rhodamine red goat anti-
mouse IgG (H + L) (Molecular Probes, Eugene, OR, USA) (dilution 1:200; 
incubation for 60 min at room temperature) for the detection of β-Tubulin 
III; A-11001 Alexa Fluor 488 goat anti-rabbit IgG (H + L) (Molecular 
Probes, Eugene, OR, USA) (dilution 1:200; incubation for 60 min at room 
temperature) for the detection of GFAP. Cells were then viewed by a Bio-
Rad MCR 1024 ES confocal laser scanning microscope (Bio-Rad, 
Hercules, CA, USA) equipped with a 15-mW Kr-Ar laser for fluorescence 
measurements and with differential interference contrast optics for 
transmission images. To minimize spectral bleed-through between the 
fluorescent channels, the emission of the different fluorochromes is 
measured by detecting the channels sequentially instead of simultaneously. 
Fluorescence was collected using a Nikon PlanApo x40 and x60 lens 
objective (Nikon Instruments SpA., Milan, Italy) and images analyzed by 
ImageJ software. 
The percentage of cells positive to β-Tubulin III and/or to GFAP was 
calculated by counting the number of stained cells over the total cells in at 
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least 15 separate fields per slides. Each experiment was performed in 
triplicate. 
 
2.2.4 Cell proliferation and cell viability 
 
Cell proliferation was evaluated as incorporation of [3H]thymidine 
(Amersham Bioscences, Little Chalfont, UK) in duplicating DNA. Cells 
were seeded in complete medium at a density of 7x104 in 6 multi-well 
culture plates; then, control and treated cells, after starvation, were labelled 
with [3H]thymidine (10 µCi/ml) at 37°C for 24 h. Cells were then harvested 
and incorporated radioactivity was measured by a liquid scintillation 
counter (Packard Instrument, Groningen, The Netherlands).  
Cell viability was evaluated by a trypan blue exclusion test. 5 µl of trypan 
blue (0.5% in PBS) was added to 40 µl of resuspended cells. Trypan blue 
excluding (live) cells were counted in a hemocytometer in 3 randomly 
selected fields and averaged. 
 
 
2.2.5 SDS-PAGE, western blotting analysis, and immunoblotting 
 
For Nestin, β-tubulin III, full length and cleaved PARP analysis, the 
specimens were treated following the same procedure of the section 2.1.4. 
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In this study the following primary antibodies were used: anti-β-Actin, 
1:10000 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-Nestin, 
1:1000 (Chemicon, Temecula, CA, USA), anti-β-Tubulin III, 1:2000 (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA); anti-PARP, 1:2000 (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA).  
 
 
2.2.6 Quantitative real-time RT-PCR 
 
RNA extraction. Total RNA was isolated from samples by “RNeasy Micro 
kit” (Qiagen S.p.A., Milan, Italy), according to the manufacturer’s 
instructions. RNA concentration and purity were checked 
spectrophotometrically. 
cDNA synthesis. RNA was reverse-transcribed using a commercial kit 
based on random primers technique (“Taqman Reverse Transcription 
Reagents”, Applied Biosystems, Foster City, CA, USA) according to 
manufacturer’s instructions. The reaction was carried out in a final volume 
of 20 µl. The reaction mix contained: buffer 1X, MgCl2 5.5 mM, dNTP 2 
mM, random hexamers 2.5 μM, RNAse inhibitor 0.4 U/μl, Reverse 
Transcriptase 1.25 U/μl. The reaction was performed with the following 
conditions: 25°C for 10 min, 48°C for 30 min and 95°C for 2 min.  
Real time PCR. mRNA expression was measured by real-time PCR 
methods based on the use of  Taqman probe. Reagents were purchased by 
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Applied Biosystems, Foster City, CA, USA, as pre-made kits: Nanog 
(Hs02387400_g1), CD15 (Hs00275643_s1), Nestin (Hs00707120_s1), 
CD271 (Hs00609976_m1), CD117 (Hs00174029_m1), GFAP 
(Hs00157674_m1), β-Tubulin III (Hs00801390_s1),  D2r 
(Hs00241436_m1), D1r (Hs00265245_s1). In a total volume of 12.5 μl, the 
PCR mixture contained 6.25 μl of Universal Master Mix (Applied 
Biosystems), 0.625 μl of the ready-made specific probe and primers mix 
(Applied Biosystems) and 2.5 μl of cDNA. The thermal cycle conditions 
were as follows: 1 hold at 50 °C for 2 min, 1 hold at 95°C for 10 min and 
45 cycles of a two step amplification protocol (95°C for 15 sec and 60°C 
for 1 min). All samples were analyzed in triplicate. Analysis of relative 
gene expression were obtained by using the 2-∆∆Ct method (Livak and 
Schmittgen, 2001). 
 
 
2.2.7 Statistical analysis 
 
The results were expressed as mean ± SEM. Comparison between groups 
was performed by the Mann-Whitney test or by the Wilcoxon test, as 
appropriate. P<0.05 was considered statistically significant. 
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2.3 Cadmium and human foetal spinal cord 
 
 
Our current knowledge of the morphological and molecular mechanisms of 
CNS development stems largely from experiments in chick, rat, and mouse 
embryos as well as in Xenopus (Schoenwolf and Smith, 2000; Colas et al., 
2001; Colas and Schoenwolf, 2003; Lawson et al., 2001; Ybot-Gonzalez et 
al., 2002; Copp et al., 2003; Gammill and Bronner-Fraser, 2002, 2003; 
Knecht and Bronner-Fraser, 2002; Basch et al., 2004; Farlie et al., 2004).  
After Cd treatment, differences in life-stage specific teratogenic response 
have been observed in several mouse strains (Robinson et al., 2009); Cd 
exposure induced a greater reduction in expression of nervous system 
development-related genes indicating a role for Cd in neural tube defects 
and formation. In addition, Cd induces neurological deficits during early 
embryonic stages in zebrafish affecting the regionalization of the neural 
tube, the pattern formation and the cell fate determination, the commitment 
of proneural genes, and the induction of neurogenesis (Chow et al., 2008).  
Several studies indicate that children of women exposed to Cd during 
pregnancy show lower motor and perceptual abilities, and that high Cd 
body burden in children is also related to impaired intelligence and lowered 
school achievement (Thatcher et al., 1982; Bonithon-Kopp et al., 1986). 
However, little is known about the molecular and cellular basis of 
developmental neurotoxicity of Cd in the sensitive early life stage of 
animals and humans. In order to investigate the effects of Cd in the human 
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CNS development, we focused on the role of Cd in affecting the 
morphology of the human foetal spinal cord during its morphogenesis. 
 
 
2.3.1 Tissue collection 
 
Twenty-five human foetal spinal cord samples (9-12 weeks gestational age) 
were collected after spontaneous or therapeutic abortions. Legal abortions 
were performed in authorized hospitals, and permission to collect tissue 
was obtained from the maternal donors at the end of the abortion 
procedure. The study protocols were approved by the University Ethical 
Committee (protocol no. 6783-04). 
 
 
2.3.2 Organ culture 
 
Each foetal spinal cord was isolated from spine and, immediately after 
collection, washed with phosphate-buffered saline (PBS) pH 7.4. The 
whole isolated spinal cord was observed by a stereomicroscope provided 
by a millimeteric scale. From the overlapping of the length of spine and 
spinal cord at this stage of development, the identification of lumbar tract 
was performed; the last 6 mm of the lumbar tract were collected and then 
cut in three fragments. Fragments were explanted onto a piece of Millipore 
 61 
filter supported by a stainless grid platform in an organ-culture dish. One 
fragment was explanted into each dish. Organ cultures  were grown in 
Dulbecco's Modified Eagle Medium (DMEM; Invitrogen, Carlsbad, CA, 
USA) serum free at 37°C in 5% CO2 for 24 h. After removing the medium, 
the samples were incubated for 24 h in fresh medium in the presence or 
absence of increasing concentrations of CdCl2  (10 µM, 100 µM). CdCl2 
solution (Sigma-Aldrich Corp.,St. Louis, MO, USA) pH 5.3 was diluted in 
the same serum-free culture medium used for the growth of the explants.  
After incubation, some  fragments were fixed in 4% buffered formalin, 
embedded in paraffin, and used for morphological detail and for 
immunohistochemical procedures. Other fragments were frozen and then 
processed for Western blot analysis. 
 
 
2.3.3 Immunohistochemistry 
 
Immunohistochemical studies were performed as described in the previous 
section 2.2.3.  Gliosis represents a remarkable response of astrocytes to all 
types of injuries of the adult and developing CNS. One of the hallmarks of 
astrocyte activation and the resulting reactive gliosis is the upregulation of 
the intermediate filament system, mainly composed by glial fibrillary 
acidic protein (GFAP) (Pekny and Nillson, 2005). The 
immunohistochemical analysis of this marker was used to evaluate the 
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possible activation of gliosis induced by the exposure of the spinal cord 
samples to Cd. Furthermore, the immunohistochemical analysis of Choline 
Acetyltransferase (ChAT), a marker for cholinergic neurons in both 
peripheral and central nervous systems (Oda, 1999), was utilized to 
evaluate the effect of cadmium on the distribution and number of motor 
neurons in the spinal cord samples. 
Briefly, transversal sections of human foetal spinal cord samples were 
incubated overnight at 4°C with the following primary antibodies: mouse 
monoclonal antibodies to human GFAP (clone 2A5, dilution 1:100) (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA) and rabbit policlonal antibody 
to human ChAT (dilution 1:150) (Abcam, Cambridge, UK). The sections 
were rinsed in PBS, incubated with biotinylated secondary antibodies 
followed by streptavidin-biotin peroxidase complex (Ultravision large 
volume detection system anti-polyvalent, Lab-Vision, Fremont, CA, USA). 
The reaction product was developed with the 3′,3′-diaminobenzidine 
tetrahydrochloride as chromogen (Sigma-Aldrich). The slides were 
examined with a Nikon Microphot-FX  microscope (Nikon, Tokyo, Japan). 
The number of ChAT positive cells was counted in 15 separate fields for 
each slide of three independent experiments. 
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2.3.4 Western blot analysis 
 
The foetal spinal cord samples were homogenized in an ice-cold lysis 
buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton 
X-100, 0.25% sodium dodecyl sulfate) supplemented with a protease 
inhibitor cocktail (Sigma-Aldrich), and centrifuged for 15 min at 4°C at 
10000g. The supernatant was collected and the protein concentration was 
measured using a Coomassie Bio-Rad protein assay kit (Bio-Rad 
Laboratories Inc.,Hercules, CA, USA). Aliquots containing 20 µg of 
proteins were diluted in 4X reducing Laemmli's sample buffer (250 mM 
Tris-HCl, pH 6.8, 20% glycerol, 8% SDS, 20% 2-mercaptoethanol, 0.008% 
bromophenol blue) and loaded onto 10% or 12% SDS-PAGE. Then, 
proteins were transferred on polyvinylidene difluoride membranes 
(Hibond-P, Amersham Bioscience, Piscataway, NJ). Membranes were 
blocked 1 h at room temperature in a 5% BSA-TTBS buffer (0.1% Tween-
20, 20 mM Tris-HCl, 150 mM NaCl, pH 7.5), washed in TTBS, and 
incubated at 4°C overnight with the following primary antibodies: anti-β 
actin (dilution 1:10000), anti-GFAP (dilution 1:1000), anti-β Tubulin III 
(dilution 1:2000), anti-Caspase 8 (dilution 1:600), anti-NGFRp75 (dilution 
1:1000) and anti-PARP (dilution 1:1000) (Santa Cruz Biotechnology). 
GFAP and β Tubulin III were used for the quantification of the glial and 
neuronal components, respectively, in the control spinal cord samples and 
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after CdCl2 exposure. The activation of the apoptotic pathway following 
CdCl2 treatment was studied analysing NGFRp75, PARP and cleaved 
Caspase 8 expression (Pehar et al., 2007; Gulisano et al., 2009; Keane et 
al., 2001). 
The incubation with the primary antibodies was followed by peroxidase 
conjugated secondary IgG treatment (Santa Cruz Biotechnology). Finally, 
the reacted proteins were revealed by the enhanced chemiluminescence 
system (ECL plus; Amersham Bioscience). Image acquisition and 
densitometric analysis were performed with Quantity One software on a 
ChemiDoc XRS instrument (Bio-Rad Laboratories Inc.). The densitometric 
analysis of each protein was normalized to β actin signal. 
 
 
2.3.5 Apoptotic assays 
 
The terminal deoxynucleotidyl transferase biotin-dUTP nick-end labelling 
(TUNEL) assay using the in situ cell death detection kit (Roche Applied 
Science, Indianapolis, IN) was utilized to detect apoptotic bodies at the 
single cell level of the human foetal spinal cords. Briefly, tissue sections 
were permeabilized with Proteinase K (20 μg/ml in 10mM Tris-HCl, pH 
7.6) for 15 min and stained with the TUNEL mixture according to the 
manufacturer instructions. Nuclei were counterstained with DAPI (4-6’-
diamidino-2-phenylindole; Invitrogen). Slides were visualized using a 
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fluorescence microscope (Nikon Microphot-FX microscope, Nikon). The 
number of TUNEL positive cells (green) colocalized with DAPI (blue), 
resulting in a cyan colour, was counted in 15 separate fields for each slide 
of three independent experiments. 
 
 
2.3.6 Statistical analysis 
 
Results are expressed as mean + SD. Comparison between groups was 
performed by the Mann-Whitney test or by the Wilcoxon test, as 
appropriate. P<0.05 or P<0.01 were considered statistically significant. 
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3 RESULTS 
 
 
3.1 Cadmium and normal/tumour human breast cell lines (MCF-7 
and MCF-10A respectively) 
 
Cell morphology. Observation by light microscopy reveals that 1 µM 
CdCl2-treated MCF-7 and MCF-10A cells (Fig.6 B, Fig.7 B) don’t show 
evident alterations in size and shape in comparison to control, untreated 
cells (Fig.6 A, Fig.7 A). The 1 µM CdCl2 exposure don’t affect the 
characteristic growth of both cell lines. The 10 µM CdCl2 exposure reveals 
a modifications in size, shape a growth of some of MCF-7 and MCF-10A 
cells in comparison to control (Fig.6 C, Fig.7 C). Some of the cells are 
distributed as small groups or separately. They appear smaller than the 
untreated cells and their shape changes to spherical morphology. These 
alterations are more evident in MCF-10A in comparison to MCF-7. The 
100 µM CdCl2 exposure reveals deep modifications in both the cell lines 
(Fig.6 D, Fig.7 D). Only few separate cells are observable; they appear 
smaller than untreated cells and with spherical morphology. The 1 mM 
CdCl2 exposure reveals a large amount of cadmium precipitate that don’t 
allow a right evaluation of this exposure (Fig.6 E, Fig.7 E); probably the 
cadmium precipitate can not allow it to fully act on the cells. 
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 D                                                             E 
 
Figure 6. MCF-7 cell morphology before and after stimulation with CdCl2. 
A: control, untreated cells at different magnifications. Cells show the typical  
MCF-7 characteristics: growth in monolayer with dome structures, polyhedric 
shape, sometimes bi- or multinucleated. B: MCF-7 cells treated with CdCl2 1 µM. 
No alterations in size and morphology are evident if compared to control cells. C: 
MCF-7 cells treated with CdCl2 10 µM. Some of the cells are distributed 
separately or as small groups. Cells are smaller if compared to untreated ones and 
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with spherical shape. D: MCF-7 cells treated with CdCl2 100 µM. Only few little 
separate cells with spherical shape are observable. E: MCF-7 cells treated with 
CdCl2 1 µM. A large amount of cadmium precipitate don’t allow a right 
evaluation of this exposure. Total magnification x200. 
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Figure 7. MCF-10A cell morphology before and after stimulation with CdCl2. 
A: control, untreated cells at different magnifications. Cells show the typical  
MCF-10A characteristics: growth in monolayer, polyhedric shape, single spherical 
nucleus. B: MCF-10A cells treated with CdCl2 1 µM. No alterations in size and 
morphology are evident if compared to control cells. C: MCF-10A cells treated 
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with CdCl2 10 µM. The cells are distributed as small groups. Some of the cells are 
smaller in comparison with untreated ones and with spherical shape. In some of 
the cells are present thin cytoplasmic extroflessions and nuclei with irregular 
shape. D: MCF-10A cells treated with CdCl2 100 µM. Only few separate little cells 
with spherical shape are observable. E: MCF-10A cells treated with CdCl2 1 µM. 
A large amount of cadmium precipitate don’t allow a right evaluation of this 
exposure. A and B, total magnification x200; C, D and E, total magnification x400. 
 
 
Cell proliferation. 
 
The results of the BrdU proliferation assay show an evident inhibitory 
effect of CdCl2 exposure on both MCF-7 and MCF-10A cell proliferation. 
In both the cell lines, the 1 µM CdCl2 exposure don’t affect significantly 
the cell proliferation in comparison to control, untreated cells. The 10, 100 
µM and 1 mM CdCl2 exposures inhibits significantly both MCF-7 and 
MCF-10A cell proliferation in a dose-dependent manner (Figg. 8 and 9). 
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Figure 8. Proliferation graph of MCF-7 cells exposed at different CdCl2 
concentrations. In x-axis, CdCl2 concentrations; Ts = control, untreated cells 
cultured in serum-free medium without phenol red, Tc = cells cultured in complete 
medium with serum. In y-axis, optical density (OD) values at 450 nm. CdCl2 1 µM 
exposure don’t affect significantly the proliferation of MCF-7 cells in comparison 
to control, untreated cells. CdCl2 10, 100 µM and 1 mM exposures deeply decrease 
the cell proliferation. 
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Figure 9. Proliferation graph of MCF-10A cells exposed at different CdCl2 
concentrations. In x-axis, CdCl2 concentrations; Ts = control, untreated cells 
cultured in serum-free medium without phenol red, Tc = cells cultured in complete 
medium with serum. In y-axis, optical density (OD) values at 450 nm. CdCl2 1 µM 
exposure don’t affect significantly the proliferation of MCF-10A cells in 
comparison to control, untreated cells. CdCl2 10, 100 µM and 1 mM exposures 
deeply decrease the cell proliferation. 
 
 
PARP-mediated apoptotic pathway. In order to determine if the treatment 
with different concentrations of CdCl2 can affect the expression of protein 
involved in DNA repair and in programmed cell death, we investigated the 
expression of poly (ADP-ribose) polymerase (PARP), a marker of caspase 
3-mediated pathway of apoptosis. Human PARP is a 116 kDa nuclear 
protein involved in repair of DNA nicks induced by various stressors and it 
is one of the substrates for caspase 3, which cleaves PARP at Asp 214 and 
Gly 215 leading to formation of 85 kDa and 25 kDa fragments during 
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apoptosis. Cleavage of PARP correlates with DNA fragmentation and 
other morphological changes making it a critical marker of apoptosis. 
The results obtained show that 1 µM CdCl2 exposure don’t affect the 
PARP-mediated levels of apoptosis in MCF-7 cells but increases 
significantly the apoptosis in MCF-10A cells in comparison to control 
untreated cells. 10 and 100 µM CdCl2 exposure increases significantly the 
PARP-mediated apoptosis in MCF-10A cells in a dose-dependent manner. 
The 10 µM CdCl2 exposure increases significantly also the PARP-
mediated apoptosis of MCF-7 cells whereas the 100 µM CdCl2 exposure 
shows a decreases of levels of apoptosis probably because of the presence 
of a cadmium precipitate that don’t allow the metals to fully affect the 
cells (Figg. 10 and 11). 
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                                 Control        CdCl2 1 µM    CdCl2 10 µM  CdCl2 100 µM 
 
Figure 10. Graph of densitometric analysis of anti-PARP western blot in MCF-7 
cells exposed at different CdCl2 concentrations. In y-axis number of pixel 
measured by appropriate image elaboration software. The 10 and 100 µM CdCl2 
exposure increases significantly the PARP-mediated apoptosis of MCF-7 cells in a 
dose-dependent manner. 
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                                             Control          CdCl2 1 µM    CdCl2 10 µM    CdCl2 100 µM 
 
Figure 11. Graph of densitometric analysis of anti-PARP western blot in MCF-
10A cells exposed at different CdCl2 concentrations. In y-axis number of pixel 
measured by appropriate image elaboration software. The 1, 10 and 100 µM 
CdCl2 exposure increases significantly the PARP-mediated apoptosis of MCF-10A 
cells in a dose-dependent manner. 
 
 
Angiogenic potential and Vascular Endothelial Growth Factor (VEGF) 
levels. The chicken embryo chorioallantoic membrane assay has been a 
model for studying neovascularization since the early 1970’s. It is perhaps 
the most widely used in vivo  assay to assess  the anti-angiogenic or 
angiogenic activity of test substances. The early chick embryo lacks a 
mature immune system and was therefore used to study tumor-induced 
angiogenesis. The basic assay is performed by implanting a membrane or 
coverslip or sponge containing the compound of interest on the chick 
* 
* * 
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embryo chorioallantoic membrane through a hole cut in the egg shell. This 
causes a typical radial rearrangement of vessels towards, and a clear 
increase of vessels around the sponge within four days after implantation. 
Blood vessels entering the sponge are counted under a stereomicroscope. 
The CAM assay is relatively simple and inexpensive and thus suitable for 
large-scale screening. The major disadvantage of this assay is that the 
CAM contains already a well-developed vascular network, which makes it 
difficult to discriminate between new capillaries and already existing ones.  
  
 
 
 
Figure 12. Examples of sponge containing PGE1 implanted in CAM surrounded by 
numerous circumfocal microvessels.  
 
The CAM assay was performed testing untreated MCF-7 cells and, 
untreated, 1 and 10 µM CdCl2-treated MCF-10A cells. The untreated 
MCF-7 cells show a strong angiogenic response if compared to very strong 
one induced by PGE1; it was due to proper characteristics of this cancer 
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cell line.  In MCF-10A cells, 1 µM CdCl2 exposure don’t affect their 
angiogenic potential in comparison to that induced by untreated cells, 
whereas 10 µM CdCl2 exposure induces an angiogenic response similar to 
that induced by untreated MCF-7 cells (Table 3).  
 
 
MCF 7 
Applied stimulus 
Circumfocal  
microvessels average 
Cells cultured for 48 h in complete 
medium with serum 
26.3 
PGE1 >30 
 
MCF-10A Cells 
Applied stimulus 
Circumfocal  
microvessels average 
Cells cultured for 48 h in complete 
medium with serum 
14.8 
Cells cultured for 48 h in serum-free 
medium without phenol red 
10 
1 µM CdCl2-treated cells 12.3 
10 µM CdCl2-treated cells 24.8 
 
Table 3. CAM assay. Summary of circumfocal microvessels count after 
implantation of sponge containing untreated MCF-7 and, untreated, 1 and 10 µM 
CdCl2-treated MCF-10A cells.  
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In order to evaluate if the angiogenic response induced in MCF-10A cells 
by 10 µM CdCl2-exposure was associated to an increased level of VEGF, 
western blot analysis was performed before and after exposure of MCF-
10A cells for 48 h at different concentrations of CdCl2.  
The results show that 1, 10 and 100 CdCl2-exposure induces a significant 
increasing of VEGF levels in a dose-dependent manner, confirming the 
hypothesis that the increasing angiogenic potential of MCF-10A cells 
treated with CdCl2 is associated with a parallel increasing of VEGF levels 
(Fig. 13). 
 
                             Tc              Ts          1 µM          10 µM     100 µM      1 mM 
 
 
Figure 13. Graph of densitometric analysis of anti-VEGF western blot in MCF-
10A cells exposed at different CdCl2 concentrations. In x-axis, CdCl2 
concentrations; Ts = control, untreated cells cultured in serum-free medium 
without phenol red, Tc = cells cultured in complete medium with serum. In y-axis 
number of pixel measured by appropriate image elaboration software. The 1, 10 
* 
* 
* 
* 
* 
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and 100 µΜ CdCl2 exposure increases significantly the VEGF levels in MCF-10A 
cells in a dose-dependent manner. The 1 mM CdCl2 exposure results are not 
rightly valuable because of the cadmium precipitate affecting the specimen. 
 
 
3.2 Cadmium and primary human neuroblast cell line FNC-B4 
 
 
FNC-B4 cell morphology. Observation by contrast phase light microscopy 
reveals that 10 µM CdCl2-treated cells (Fig.6, panels C and D) show a 
bulky body shape and long neuritic processes analogue to control, untreated 
cells (Fig. 6, panels A and B); synaptic bundles are well represented and 
manifold intercellular contacts are clearly evident. After 100 µM CdCl2 
exposure, cell morphology appears significantly modified (Fig. 6, panels E 
and F); cells are stretched and thinner even though neurites are still present, 
normal in length, and there are numerous synaptic bundles.  
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Figure 6. FNC-B4 cell morphology before and after stimulation with CdCl2. 
Panels A and B: control, untreated cells at different magnifications. Cells show the 
typical neuronal morphology with neuritic processes and manifold intercellular 
contacts. Panels C and D: 10 μM CdCl2-treated neuroblasts. Cell shape and 
synaptic network appear unaffected by the treatment in comparison to control 
neuroblasts. Panels E and F: 100 μM CdCl2-treated neuroblasts. The exposure 
induces changes of the polyedric cell shape so that FNC-B4 neurons acquired a 
spindle shape morphology; cytoplasmic processes are well represented. 
Contrast phase light microscopy. A, C and E panels: total magnification x40.         
B, D and F panels: total magnification x400. 
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Cytoskeleton and vimentin network organization. Analysis by confocal 
laser scanning microscopy shows that exposure of  FNC-B4 human 
neuroblasts to a high concentration of CdCl2 results in  significant 
cytoskeletal network modifications. In fact, after 10 μM CdCl2 exposure, 
vimentin appears unaffected in its distribution and organization (Figure 7, 
panels B) in comparison to untreated cells (Fig. 7, panels A); both in 10 μM 
CdCl2-treated and in control cells, vimentin is evident and uniformly 
distributed in the cell bodies and in the neurites. Instead, after 100 μM 
CdCl2 exposure (Fig. 7, panels C), vimentin appears accumulated and 
aggregated in neuronal cell bodies and axons giving FNC-B4 cells a deeply 
modified cytoskeletal phenotype. Both control and treated cells (with low 
and high concentrations of CdCl2 ) show branched neurites and several 
synaptic contacts, considered hallmarks of neuronal plasticity and of 
differentiation (Cowen and Gavazzi, 1998).  
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Figure 7. FNC-B4 cytoskeletal modifications before and after stimulation with 
CdCl2. Panels A: control, untreated cells at different magnifications. Vimentin, 
revealed by appropriate primary and fluorescent secondary antibodies, appears in 
green. Fluorescence appears uniformly distributed in the cell bodies and 
outgrowths. Panels B: 10 μM CdCl2-treated cells. CdCl2 treatment does not 
significantly affect vimentin distribution and architecture. 
Panels C: 100 μM CdCl2-treated cells. Vimentin appears denser and closely 
packed in the cell body and in the outgrowths in comparison to control and to 10 
μM CdCl2-treated cells.  Immunohistochemistry and confocal laser scanning 
microscopy. Total magnification in each panel: from left to right x40, x400 and 
x600, respectively. 
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Cell proliferation and viability. In order to investigate the role of CdCl2 on 
cell proliferation, we measured the [3H]thymidine incorporation in control 
and treated cells. Neuroblasts, treated with 10 µM CdCl2, have a 
statistically significant increase of [3H]thymidine incorporation in 
comparison to control, untreated cells (Table 3).  In contrast, 100 µM 
CdCl2-treated  FNC-B4 cells, show a significant decrease in the 
incorporated radioactivity, in comparison both to control and to 10 µM 
CdCl2-treated cells (Table 3). Cell viability, measured by trypan blue 
exclusion assay, is not significantly affected by 10 µM CdCl2 treatment in 
comparison to control, untreated cells. When cells were exposed to 100 µM 
CdCl2, the number of trypan blue positive cells increased (15%, p<0.05). 
 
Treatments                                 Cell Proliferation 
__________________________________________________ 
  10 µM CdCl2    119 ± 6 
100 µM CdCl2      23 ± 7 
__________________________________________________ 
 
Table 3. Cell proliferation is assessed by [3H]thymidine 
incorporation in FNC-B4 cells stimulated with increasing 
concentrations of CdCl2. Results are expressed as percent increase 
over the control value (100%); each value of n=3 experiments 
represents the mean  +  SEM.  
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PARP-mediated apoptotic pathway. In order to determine if the treatment 
with different concentrations of CdCl2 can affect the expression of protein 
involved in DNA repair and in programmed cell death, we investigated the 
expression of poly (ADP-ribose) polymerase (PARP), a marker of caspase 
3-mediated pathway of apoptosis. Human PARP is a 116 kDa nuclear 
protein involved in repair of DNA nicks induced by various stressors and it 
is one of the substrates for caspase 3, which cleaves PARP at Asp 214 and 
Gly 215 leading to formation of 85 kDa and 25 kDa fragments during 
apoptosis. Cleavage of PARP correlates with DNA fragmentation and other 
morphological changes making it a critical marker of apoptosis. In FNC-B4 
cells treated with CdCl2 the PARP-mediated apoptotic pathway is activated 
in a dose-dependent manner: the cleaved form of PARP progressively 
increases (and the full length of PARP decreases) when cells are treated 
with 10 and 100 µM CdCl2  in comparison to control, untreated cells (Fig. 
8). 
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Figure 8. Western blotting analysis of Nestin, β-Tubulin III, and 
PARP in FNC-B4 neuroblsts before and after stimulation with CdCl2. 
Western blotting analysis for Nestin and β-Tubulin III expression 
reveals bands migrating approximately at the expected 220 and 50 
kDa molecular sizes, respectively. With the increasing of CdCl2 doses, 
the expression of Nestin progressively decreases whereas the 
expression of β-Tubulin III increases. Western blotting analysis for 
full length (116 kDa) and cleaved (85 kDa) PARP shows a significant 
increase in the cleaved form expression when FNC-B4 cells are 
treated with 100 μM CdCl2. 
 
 
Gene and protein expression. FNC-B4 cells, obtained from the human fetal 
olfactory epithelium, have at the same time the properties of immature 
neurons and the ability to differentiate and express both neuronal proteins 
as well as olfactory specific markers (Vannelli et al., 1995). When FNC-B4 
cells are exposed to 10 and 100 µM CdCl2, the expression of several 
somatic markers such as Nanog (a homeodomain transcription factor, 
marker of pluripotency), CD15 (a carbohydrate antigen associated to the 
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extracellular matrix and marker of highly proliferative cells) and Nestin (a 
protein associated with neural stem cell) appear significantly decreased, 
with a concentration-dependent pathway, in comparison to untreated, 
control cells (Fig. 9, A). Nevertheless, after 10 and 100 µM CdCl2 
treatments, GFAP (glial fibrillary acid protein) (Fig. 9, B) and β-Tubulin 
III (Fig. 9, C) expression increase, suggesting the possibility of a multi-
differentiation into different cell subtypes, neurons or astrocytes. In order 
to confirm the trend of FNC-B4 cells that differentiate in response to CdCl2 
exposure, the expression of β-Tubulin III and Nestin proteins was 
evaluated. Western blotting analysis confirmed that while β-Tubulin III 
expression increases in a dose-dependent manner, the expression of Nestin, 
significantly decreases (Fig. 8).   
Since the simultaneous over expression of GFAP and β-Tubulin III was 
somewhat intriguing, we analyzed, by confocal laser scanning microscope, 
the localization of GFAP and β-Tubulin III in control and treated cells. 
Data obtained demonstrated that GFAP and β-Tubulin III co-localize in 
CdCl2 treated cells, with a dose-dependent pathway (Fig. 10). In particular, 
control cells (Fig. 10, A, B, C and J) are positive to β-Tubulin III (43.38 ± 
2.83 %, n=3) and virtually to GFAP (0.42 ± 0.12 %, n=3); 10 µM CdCl2 
treated cells (Fig. 10, D, E, F and J) are positive both to β-Tubulin III 
(66.42 ± 3.24 %, n=3) and to GFAP (7 ± 2 %, n=3). Treatment  with 100 
µM CdCl2 (Fig. 10, G, H, I and J) increased the number of cells positive to 
β-Tubulin III (93.7 ± 3.8 %, n=3) and GFAP (47 ± 3 %, n=3). After 10 and 
100 µM CdCl2 treatment the co-localization of β-Tubulin III and GFAP in 
FNC-B4 neuroblasts was 7 ± 2 % (n=3) and 47 ± 3 % (n=3) respectively. 
In the merged images (Fig. 10, C, F, I and J) the yellow colour indicates a 
co-localization of β-Tubulin III with GFAP in the treated cells.  
Among cell markers suggesting a proliferative cell phenotype, we analyzed 
the expression of CD117 gene (encoding a receptor for stem cell factor) 
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since it identifies and characterizes neurons with proliferative and stem 
phenotypes. CD117 is over-expressed in FNC-B4 cells treated with 10 µM 
CdCl2 while the decrease of expression of this marker is dramatic when 
cells are stimulated with 100 µM CdCl2 (Fig. 11, A).  Since dopamine, in 
parallel to its action in odour processing, plays a growth factor-like role in 
the permanent neurogenesis observed in the olfactory epithelium, by a 
direct dopamine D1receptor (D1r) or D2receptor (D2r)-mediated action, we 
evaluated the expression levels of dopamine D1r and dopamine D2r before 
and after CdCl2 treatments. Our data showed that CdCl2 induced on FNC-
B4 neuroblasts an increase of dopamine D1r expression in a dose-
dependent pathway (Figure 11, B); on the contrary, dopamine D2r 
expression dramatically decreased after stimulation both with 10 and 100 
µM CdCl2 (Fig. 11, C). 
 
 
 
 
 
 
 
 
 88 
 
 
Figure 9. Quantitative gene expression analysis (Nanog, CD15, Nestin, GFAP and 
β-Tubulin III) in FNC-B4 before and after stimulation with CdCl2. A: mRNA 
expression of neural markers. Nanog, CD15 and Nestin decrease in 10 and 100 μM 
CdCl2-treated neuroblasts. mRNA expression of CD271 (nerve growth factor 
receptor), is high both in control (CTL) and in treated cells, confirming the 
viability of control and CdCl2-exposed neuroblasts. B: mRNA expression of GFAP 
progressively increases when FNC-B4 cells are stimulated with 10 and 100 μM 
CdCl2. C: mRNA expression of β-Tubulin III increases when neuroblasts are 
stimulated with 10 and 100 μM CdCl2. Results are calculated accordingly to the 
comparative cycle threshold method using the GAPDH as reference gene for 
normalization and are expressed as percentage of data obtained in the untreated, 
control cells (CTL). Data are reported as mean ± SEM from at least three separate 
experiments; * p<0.05 vs. control.  
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Figure 10. β-Tubulin III and GFAP expression in FNC-B4 neuroblsts before and 
after stimulation with CdCl2. A, B, C: control, untreated cells. Only cells positive to 
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β-Tubulin III but no cells positive to GFAP have been detected. Merged image 
shows no co-localization of  β-Tubulin III and GFAP in the same cells. D, E, F: 10 
μM CdCl2-treated cells. After the treatment, numerous cells positive to β-Tubulin 
III and some cells positive to GFAP have been detected. In the merged image the 
yellow color indicates the co-localization of β-Tubulin III and GFAP in the same 
cells. G, H, I: 100 μM CdCl2-treated cells. Most of the cells are positive both to β-
Tubulin III  and to GFAP; co-localization of β-Tubulin III and GFAP is evident in 
the merged image (yellow colour). Immunohistochemistry and confocal laser 
scanning microscopy. Total magnification: x630. L: cells were scored as either 
positive or negative for  β-Tubulin III and /or GFAP, and results were expressed as 
the percentage of positive cells ± SE (calculated by counting the number of stained 
cells over total in 15 separate fields per slide). In control, only cells positive to β-
Tubulin III were detected; the number of cells positive both to β-Tubulin III and to 
GFAP after stimulation with 10 and 100 μM CdCl2 significantly increased 
(*p<0.01 vs. control cells) with a dose-dependent pathway. Ordinate: cells positive 
to β-Tubulin III and to GFAP (% over total cells); columns are mean ± SE. Results 
are obtained from three separate experiments (n=3). 
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Figure 11. Quantitative gene expression analysis of CD117 and of dopamine D1 
and D2 receptors in FNC-B4 before and after stimulation with CdCl2. A: mRNA 
expression of CD117 is significantly decreased after 100 μM CdCl2 treatment in 
comparison with 10 μM CdCl2 exposure and with control (CTL) cells. B: the 
exposure of FNC-B4 cells to CdCl2 causes a dose-dependent increase in mRNA 
expression of dopamine D1 receptor. C: mRNA expression of dopamine D2 
receptor is decreased in FNC-B4 cells after CdCl2 treatments. 
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3.3 Cadmium and human foetal spinal cord 
 
 
Treatment of the human foetal spinal cord specimens for 24 h with CdCl2 
10 and 100 µM induced deep morphological changes in the spinal cord 
feature (Fig. 12). The ventral horns showed relevant changes both in cell 
number and distribution after CdCl2 treatment compared to the untreated 
specimens. When increasing the CdCl2 concentration (10 and 100 µM) the 
cell number in the ventral horns appeared dramatically decreased and the 
characteristic aspect of the ventral horns shape deeply modified (Fig. 12). 
In the dorsal horns of the spinal cord, after the same CdCl2 treatment, a 
dorsally-directed enlargement of the central canal and a progressive 
deformation of the dorsal median septum clearly appeared (Fig. 12). After 
CdCl2 100 µM treatment the dorsal median septum showed a total 
overthrow with consequent disarrangement of the spinal cord dorsal region 
morphology (Fig. 12). 
Upregulation of intermediate filament proteins, in particular glial fibrillary 
acidic protein (GFAP), by reactive astrocytes is perhaps the best known 
hallmark of reactive astrocytes and reactive gliosis (Pekny and Nillson, 
2005). Therefore, GFAP expression after CdCl2 treatment was evaluated by 
immunohistochemistry and Western blot analysis (Fig. 13). 
Immunohistochemical study showed an increase in the expression of GFAP 
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after CdCl2 treatment in comparison to untreated specimens (Fig. 13 A-B). 
These data were confirmed by Western blot analysis (Fig. 13C).  
The expression of β Tubulin III, marker of immature neurons (Gulisano et 
al., 2009), was also evaluated. The western blot analysis demonstrated a 
significant decrease of  β Tubulin III expression after CdCl2 exposure 
respect to control specimens (Fig. 14A), indicating a loss of neural cells 
following the treatment. 
The reduction of the neuronal compartment was accompanied by the 
activation of the apoptotic pathway, as demonstrated by the Western blot 
analysis of some apoptotic markers. In fact, the exposure of human foetal 
spinal cord specimens to increasing concentrations of CdCl2 caused an  
expression level increase of both full-length and cleaved PARP (Fig. 13 D). 
Furthermore, CdCl2 treatment induced upregulation of Caspase 8 (Fig. 14 
C), commonly not expressed in neural precursor cells and required for 
initiating the apoptotic cascade (Ricci-Vitiani et al., 2004) as well as of 
NGFRp75 (Fig. 14 B), specifically involved in motor neuron cell death 
(Pehar et al., 2004). 
In order to focus our study on the effects of CdCl2 on the spinal cord 
ventral horns, the immunohistochemical analysis of ChAT, a specific 
marker of motor neurons, was performed (Fig. 15 A). The number of ChAT 
positive neurons was significantly decreased after the treatment with 
different concentrations of CdCl2 in a dose dependent manner (Fig. 15 B). 
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According to the decrease of ChAT positive cells, the number of apoptotic 
cells in the ventral horns, as revealed by TUNEL assay (Fig. 15 C-D), 
increased in the specimens treated with CdCl2 in comparison to control in a 
dose dependent manner.   
 
 
 
Figure 12. Morphological modifications after treatment with CdCl2 in the lumbar 
region of spinal cord from a 10-week-old human foetus. Fragments of spinal cord 
were cultured on organ-culture dishes in serum-free medium for 24 h and then 
untreated or incubated with CdCl2 (10 and 100 µM). In control specimens (CTL) 
the typical shape of dorsal and ventral horns was observed; dorsal median septum, 
ventral median fissure and ependymal canal were correctly formed. After the 
treatment with 10 µM CdCl2 the cell density in the ventral horns was significantly 
reduced and the white matter (in light pink) appeared more evident. Dorsally, the 
median septum (), extending towards the dorsal surface of the spinal cord, 
showed a degenerative aspect. When human foetal spinal cord was treated with 
100 µM CdCl2, the decrease of cell density in the ventral horns was evident. In the 
posterior area, the dorsal median septum, after a total dehiscence, was occupied by 
a rarefied zone with a scant number of cells and with the aspect of white matter. 
Haematoxylin Eosin. Total magnification: x40 
 
CdCl2 10µM CdCl2 100µM CTL 
dorsal horn 
ventral horn 
dorsal horn 
ventral horn 
dorsal horn 
ventral horn 
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Figure 13. GFAP expression in the lumbar region of human spinal cord from 9-12-
week-old fetuses. A: in control specimens only few GFAP positive cells were 
detected (in black), while the GFAP positivity after stimulation for 24h with 10 and 
100 µM CdCl2 was significantly increased. Total magnification x40. B: particular 
of the ventral horns, total magnification x100. C: western blot analysis of total 
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lysates from spinal cord untreated (CTL) or following 24h of incubation with 
CdCl2.  Western blot analysis with anti-GFAP antibody revealed a single band 
migrating approximately at the expected 50 kDa molecular mass. Note the 
increased expression of GFAP after CdCl2 treatment. D: the densitometric 
quantification of the bands, expressed as percentage over control (taken as 100%), 
confirmed the increased GFAP expression following 24h CdCl2 exposure. β actin 
signal was used for the normalization of GFAP protein expression. Data were 
obtained from three separate experiments (**P<0.01 CdCl2 10 and 100 µM vs 
CTL).  
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Figure 14. Western blot analysis of spinal cord protein extract stained with 
antisera to β Tubulin III, NGFRp75, PARP or caspase 8.  Western blot analysis of 
spinal cord samples from 9-12-week-old human fetuses showed a significant 
decreased expression of the neuronal marker β Tubulin III following 24h CdCl2 
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exposure, indicating a neuronal loss after the treatment (panel A). These data were 
confirmed by the analysis of some apoptotic markers (NGFRp75, PARP and the 
cleaved form of caspase 8) that resulted upregulated after CdCl2 exposure. The 
quantification of bands corresponding to the proteins examined by Western blot 
was made directly on the films by Quantity One Software and was expressed as 
percentage over control (taken as 100%) (panels B, C, D). β actin signal was used 
for the normalization of each protein expression (panel E). Data were obtained 
from three separate experiments (*P<0.05 CdCl2 10 and 100 µM vs CTL). 
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Figure 15. Immunohistochemical analysis of ChAT and TUNEL assay in the 
ventral horns of spinal cord samples from 9-12-week-old human fetuses. A: cross 
sections (conducted at lumbar level) of human foetal spinal cord were 
immunostained with anti-ChAT, a specific marker of motor neurons (red 
positivity). Cell nuclei were counterstained with Haematoxylin. Total 
magnification x100. B: the number of ChAT positive cells in control and treated 
specimens was counted and expressed as percentage over control (taken as 100%). 
ChAT positive motor neurons significantly decreased in the specimens treated with 
CdCl2 10 and 100 µM in comparison to control specimens, in a dose dependent 
manner. Data were obtained counting 15 separate fields for each slide of three 
independent experiments (**P<0.01 CdCl2 10 and 100 µM vs CTL; P<0.05 CdCl2 
100 µM vs CdCl2 10 µM). C. TUNEL (dUTP nick-end labeling) for the staining of 
apoptotic cells was performed on cross sections of human foetal spinal cord at 
lumbar level. Cell nuclei were counterstained with DAPI (blue); the nuclei of 
apoptotic cells were stained with green fluorescence. The merged cyan colour 
identified the apoptotic cells above the number of total cells. D: the number of cyan 
cells in control and treated specimens was counted and expressed as percentage 
over control (taken as 100%). TUNEL positive cells significantly increased after 
CdCl2 treatment in comparison to control untreated specimens in a dose 
dependent manner. Data were obtained counting 15 separate fields for each slide 
of three independent experiments (**P<0.01 CdCl2 10 and 100 µM vs CTL; P<0.05 
CdCl2 100 µM vs CdCl2 10 µM). 
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4 CONCLUSIONS 
 
4.1 Cadmium and normal/tumour human breast cell lines (MCF-7 
and MCF-10A respectively) 
 
 
The analysis of the biological effects of cadmium on normal and tumor 
breast cell lines (MCF-7 and MCF-10A respectively) shows that CdCl2 
exposure affects the morphology and the proliferation both of MCF-7 and 
MCF-10A cells.  The 10 µM CdCl2 exposure reveals a modifications in 
size, shape a growth of some of MCF-7 and MCF-10A cells in comparison 
to control, untreated cells. Some of the cells are distributed as small groups 
or separately. They appear smaller than the untreated cells and their shape 
changes to spherical morphology. These alterations are more evident in 
MCF-10A in comparison to MCF-7. The 100 µM CdCl2 exposure reveals 
deep modifications in both the cell lines. Only few separate cells are 
observable; they appear smaller than untreated cells and with spherical 
morphology. The 10, 100 µM and 1 mM CdCl2 exposures inhibits 
significantly both MCF-7 and MCF-10A cell proliferation in a dose-
dependent manner. Moreover 1 µM CdCl2 exposure don’t affect the 
PARP-mediated levels of apoptosis in MCF-7 cells but increases 
significantly the apoptosis in MCF-10A cells in comparison to control 
untreated cells. 10 and 100 µM CdCl2 exposure increases significantly the 
PARP-mediated apoptosis in MCF-10A cells in a dose-dependent manner. 
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The 10 µM CdCl2 exposure increases significantly also the PARP-
mediated apoptosis of MCF-7 cells whereas the 100 µM CdCl2 exposure 
shows a decreases of levels of apoptosis probably because of the presence 
of a cadmium precipitate that don’t allow the metals to fully affect the 
cells. These results emphasize that MCF-10A cells are more sensitive than 
MCF-7 to CdCl2 exposure toxic effects.  
Angiogenic potential evaluated using the CAM assay show that MCF-7 
cells present a strong angiogenic response due to their typical tumor 
characteristics. Moreover, in MCF-10A cells, 10 µM CdCl2 exposure 
induces an angiogenic response similar to that induced by untreated MCF-
7 cells; these increasing of the angiogenic potential of MCF-1oA after 
CDCl2 exposure is associated to a parallel increasing of VEGF levels as 
evaluated by western blot analysis. 
 
 
4.2 Cadmium and primary human neuroblast cell line FNC-B4 
 
 
This investigation of the biological effects of cadmium on primary human 
neuroblast cell line FNC-B5 provides the first evidence that CdCl2 is 
simultaneously able to strongly inhibit the growth of developing neurons 
(FNC-B4) and induce differentiation of neural progenitor cells into distinct 
neuronal and glial cell lineages.  
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Environmental pollutants and transition metals such as cadmium have 
short-term and long-term effects on neuron development. Some studies 
demonstrate that cadmium may disturb the natural oxidation/reduction 
balance in cells through various mechanisms, which interferes with cellular 
signaling and gene expression systems.  
In fact, in some cell lines such as human neuroblastoma NB-1 cells, 
exposure to CdCl2 induces a significant neurite outgrowth, suggesting a 
role in neuron differentiation for cadmium). Furthermore, administration 
for 3 h of 100 or 150 μM CdCl2 inhibits proliferation and induces several 
functional differentiation markers in some cell lines.  
The results of this study show that the treatment of human immature 
neuron FNC-B4 cells, with different concentrations of CdCl2 significantly 
affects cell growth. Indeed, low concentrations of CdCl2 stimulates cell 
growth, whereas higher concentrations causes a decrease in cell 
proliferation. The latter effect, according to previous study, is associated to 
morphological and biochemical alterations as well as to induction of 
apoptotic cell death consistent with the induction of cell differentiation 
toward glial/neural precursor. 
Low concentrations of CdCl2 induces the appearance of a proliferative 
phenotype in FNC-B4 cells associated with an increase in CD117 gene 
expression, a marker which is associated with cellular proliferative 
potential. The exposure of FNC-B4 neuroblasts to high concentrations of 
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CdCl2 induced significant morphological and cytoskeletal alterations, 
remarkable reduction of proliferation and of CD117 gene expression. 
Several cells also show signs of apoptosis as confirmed by morphological 
observation and by the increased level of cleaved PARP. These findings 
suggest that CdCl2, depending on its concentration, is able to change and 
thus regulate distinct biological responses. The exposure of FNC-B4 to 
increasing concentrations of CdCl2, induces a significant decrease in the 
expression of some neural markers such as Nanog, Nestin and  CD15. This 
latter gene distinguishes highly proliferative cells and it is strongly 
expressed in neuronal regions with prolonged neurogenesis i.e. the 
olfactory epithelium. On the other hand, neural/glial differentiation markers 
such as GFAP and β-Tubulin III became robust. Moreover, the present 
study shows that high concentration of CdCl2 caused a significant increase 
of  the marker, CD133. CD133 is a plasma membrane marker found in 
several types of somatic stem cells, including neural stem cells; however, 
the expression of CD133 is not limited to stem progenitor cells but it also 
occurs both in adult and in differentiated cells. Irrespective of cell type, 
CD133 is specifically associated with plasma membrane protrusions and 
with the alterations of cell surface deeply involved in neuronal 
differentiation. In agreement the aforementioned studies, this study 
suggests that the treatment with CdCl2  forces FNC-B4 cells to change from 
immature cells to more differentiated cells, expressing both glial and neural 
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markers. We think that CD133 may be considered as a new marker to 
define more differentiated progenitor cell in vitro. 
Recent studies suggest that dopamine may play a crucial role as a 
modulator in olfactory discrimination and in olfactory processing as well as 
in several disorders with olfactory deficits, such as Parkinson disease, 
characterized by altered dopamine homeostasis in olfaction-related brain 
regions. However, dopamine is present in the brain early in development 
and functional dopamine receptors are expressed in the central nervous 
system prior to the onset of synaptogenesis suggesting a role for dopamine 
in brain development that may be independent of its role at the synapse in 
the mature central nervous system. Neurotransmitters such as dopamine 
can influence brain development by modulating neurogenesis or neuronal 
and glial cell differentiation. Recent studies show that dopamine receptor 
activation influences the cell cycle of neuroepithelial cells in the lateral 
ganglionic eminence and in the cerebral wall. The findings of this study 
demonstrate that CdCl2 simultaneously up-regulates dopamine D1 receptor 
expression and down-regulates dopamine D2 receptor expression. In 
particular, increasing CdCl2 concentrations induces a progressive increase 
in dopamine D1 receptor expression, while low and high CdCl2 
concentrations caused a significant decrease in dopamine D2 receptor 
expression. Since dopamine D1 and D2 receptor activation produces 
opposite effects on precursor cell activity, we can hypothesize that 
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dopamine's overall effects correlate with relative numbers and activity of 
each receptor subtype expressed on the FNC-B4- neuroblast cell line.  
During development of the nervous system, neural stem cells give rise to 
both the neuronal and glial population.  A dominant model of neural 
development is that neuronal and glial  lineages diverge early, with 
neuroepithelial precursor giving rise to neuron-restricted and glial-
restricted progenitors. Although a set of molecular markers have been 
defined for neural progenitors, their identification, characterization and 
function in neuronal and glial lineages have generated much discussion and 
are still not fully understood. Recent studies have demonstrated that some 
radial glia, the first cells differentiated within the embryonic 
neuroepithelium, have stem cell characteristics and produce neurons and 
astrocytes. In the adult brain, neural stem cells are found in two regions of 
the periventricular germinal matrix, the subventricular or subependymal 
zone of the lateral ventricles and the subgranular zone of the hippocampal 
dentate gyrus. In addition to the “neurogenic” regions of the brain, 
multipotential neural stem cells are isolated from postnatal cerebellum. 
These cells express markers associated with neural progenitor and stem 
cells as well as GFAP, a defining marker of astroglia. GFAP-positive cells, 
with characteristics of neural stem cells are obtained from fetal human 
brain parenchyma. These cells co-express  both glial and neuronal markers, 
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and they are able to differentiate into distinct neuronal and glial cell 
lineages. 
From the data of this study emerge that FNC-B4 neuroblasts treated with 
high concentration of CdCl2 are forced to differentiate toward cells 
expressing both neuronal (β-Tubulin III) and glial (GFAP) markers; this 
neuronal/glial precursor still expresses vimentin, even though differently 
arranged in comparison to control cell and to neuroblasts treated with low 
concentration of CdCl2, suggesting the possibility to evolve both toward 
neuron or toward glial cells. As a matter of fact, vimentin is a critical 
cytoskeletal protein, involved in oxidative stress response and initially 
expressed by nearly all neuronal precursor but substituted by 
neurofilaments in post mitotic neurons; the presence of vimentin in post 
mitotic cells is considered a typical marker of glial cells. 
A remarkable feature of olfactory neurons is that they have a half-life in the 
range of weeks and are replaced by new neurons that differentiate from a 
progenitor present in the olfactory epithelium. Because FNC-B4 cell 
exposure to CdCl2 induces a decrease in some neural markers and an 
increase in neural differentiation marker expression we can hypothesize 
that CdCl2 might represent a specific signal for olfactory lineage 
differentiation. We can also speculate that CdCl2  in FNC-B4 neuroblasts 
might represent a selective cue by which, in a heterogeneous degree of 
maturity of the primary cell culture, the more committed progenitors and/or 
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differentiated mature neurons rapidly move towards apoptosis, whereas the 
undifferentiated neural precursors are positively selected and forced to a 
state of active differentiation into glial cells and/or neurons, via an 
intermediate precursor expressing both glial and neuronal markers. The 
identification of the neuronal/glial cell precursor, the signaling that 
regulates self-renewal and differentiation of FNC-B4 cells, is basic and 
crucial for understanding the mechanisms of pathological processes leading 
to neurological diseases. 
 
 
4.3 Cadmium and human foetal spinal cord 
 
 
It is well established that multiple gene-environmental interactions which 
govern different biochemical pathways are linked to the etiopathogenesis of 
neurodegenerative diseases. Among the environmental agents linked to 
neurodegenerative diseases, pollutants deriving from industries certainly 
play a crucial role. Although indications exist that industrial chemicals can 
cause damages on central nervous system during its development, only  5 
of  80,000 known chemicals have been identified as toxic to human 
neurodevelopment. The heavy metals such as Cd are certainly likely 
candidates because of their proven neurotoxicity, ubiquitous nature and 
causal epidemiological link with neuropsychological disorders and 
neurodegenerative diseases. 
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The neurotoxic effects of Cd have been reported in neonatal mouse brain 
and young rat brain but only few data are available about the role of Cd on 
human developing central nervous system. In humans, occupational 
exposure to Cd is associated with neuropsychological disorders, and Cd 
exposure is reported to be a possible cause of ALS; Cd is shown to 
selectively damage striatum, and Parkinsonism has been reported in a 64-
year-old man exposed to Cd at a high dose.  Cd-induced damages on CNS 
may be explained by the Cd ability of activating apoptotic pathways. 
Recently, several reports have shown that cadmium can induce apoptosis of 
many tissues and cells both in vivo and in vitro, such as the cells of the 
respiratory system, the testis, the kidney, the liver, and the immune system. 
This evidence indicates that apoptosis probably plays a very important role 
in acute and chronic intoxication by Cd. 
In human lung epithelial fibroblast cell line, Cd has been shown to cause 
apoptosis by the Caspase-8-dependent Bid cleavage, activation of Caspase-
9 and -3, and PARP cleavage. In human lymphoma cells it has been 
demonstrated that Caspase 8 may be the most apical Caspase induced by 
Cd in the apoptotic Caspase-dependent pathway; furthermore, a recent 
research has demonstrated that the activation of NGFRp75 induced motor 
neuron apoptosis in rat embryonic spinal cord. 
Besides the activation of different apoptotic pathways, recent researches 
have demonstrated that astrocytes play a complex role in repair after spinal 
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cord injury. The vicinity of  a traumatic injury, environmental cues 
associated with cell damage and neuroinflammation induces astrocytes to 
proliferate, migrate, differentiate and form a dense network bordering the 
lesion site. This response not only contributes to the formation of the glial 
scar but it also provides support and guidance for axonal growth  and aid in 
improving functional recovery after spinal cord injury.  
Several studies using GFAP-deficient mice demonstrated that animals 
lacking GFAP have increased hippocampal degeneration after brain injury , 
form an abnormal glial scar after brain and spinal cord lesions, produce 
astrocytes with impaired migratory abilities in vitro, and are more 
susceptible to death after cervical spinal cord injury. 
Reactive astrocytes can arise either from astrocytes that are already present 
at the time of injury, or from progenitor cells that are found either in 
regions surrounding the central canal or the subpial region of the spinal 
cord. 
This study focused on the effects of Cd on human spinal cord at early 
stages of development, when its vulnerability to neurotoxicants is high. 
Spinal cord slices were used in vitro: an experimental model in which the 
tissue cytoarchitecture and extracellular matrix connections are preserved, 
and the interactions between neuronal and glial cells are analogues to those 
in vivo. 
 111 
This study provided the first evidence that Cd is able to affect two different 
cell populations in developing human spinal cord; in fact, important signs 
of apoptosis are evident in motor neurons and, at the same time, a 
significant gliosis arises. 
The findings of this study indicate that cleavage of Caspase 8, NGFRp75, 
and PARP with consequent specifically reduction of the motor neurol 
compartment. Cd-induced apoptosis is associated to a significant gliosis as 
demonstrated by a significant increase of GFAP expression. The number of 
GFAP positive cells increased after Cd treatment surrounding the area of 
motor neuron loss. As well as in the proximity of the ependymal canal. The 
significance of this increased GFAP expression is not yet clear. It is 
possible that Cd may activate astrocytes, thus playing a role in the 
organizational events of glial scar formation. This increase in GFAP 
expression may also be related to the attempt of glial cells to be supportive 
of recovery. Motor neurons death and consequent glial activation observed 
in this study after Cd treatment, may be explained considering the 
molecular mechanism of Cd. In fact, Cd ion easily substitutes for the 
Calcium and Zinc ions in several biological systems because it carries the 
same charge and it has a similar radius. For its ability in substituting and/or 
displacing Calcium and Zinc, Cd is involved in the generation of reactive 
oxygen species, inhibition of DNA repair enzymes, deregulation of cell 
proliferation as well as DNA methylation. 
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Disregulation of calcium and abnormal Calcium homeostasis are decisive 
in long-term neurodegeneration diseases such as Alzheimer’s disease, 
Parkinson’s disease, Huntington’s disease, and ALS. During CNS 
development, when the permeability of BBB is changing, Cd, interfering 
with biochemical events where Calcium or Zinc are involved, might deeply 
affect the developing of nervous structures. 
Most existing data on acute and chronic developmental neurotoxic effects 
have been obtained in animal studies, and only a few studies have 
specifically dealt with human developmental neurotoxicity.  
This study provided the first evidence that Cd is able to induce both a 
decrease in β Tubulin III and ChAT expression and an increase in GFAP 
and apoptotic markers expression during human spinal cord development.  
Apoptosis plays an important role during embryonic development and 
tissue homeostasis. This complex process is particularly important in the 
development of the central nervous system, involving an interplay between 
intrinsic cellular programs and extrinsic cues such as growth factors. 
Our results in human spinal cord showed that the exposure to Cd caused an 
increase in NGFRp75 expression. Our observations also indicate that Cd 
can induce increased number of apoptotic cells such as motor neurons. We 
therefore speculated that Cd-induced neurotoxicity can be caused by 
impaired neurogenesis, resulting in markedly reduced neuronal 
compartment. In this study we also showed that Cd exposure is associated 
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to a significant gliosis as demonstrated by the increase of GFAP 
expression. Recent researches have demonstrated that astrocytes play a 
complex role in repair after spinal cord injury. The vicinity of a traumatic 
injury, environmental cues associated with cell damage and 
neuroinflammation induce astrocytes to undergo hypertrophy, proliferate, 
migrate, differentiate, and form a dense network bordering the lesion site.  
Our results in human spinal cord are in agreement with those of the 
aforementioned studies. In fact, the number of GFAP positive cells 
increased after Cd treatment not only in the ventral horns in the vicinity of 
motor neuron loss, but also in the proximity of the ependymal canal. The 
significance of this increased  GFAP expression is not yet clear. It is 
possible that Cd may activate astrocyte, thus playing a role in the 
organizational events of glial scar formation. This increase in GFAP 
expression may also be related to the attempt of glial cells to be supportive 
of recovery. 
In conclusion, our study extends to a human model previous observations 
in animal models on the dual role of Cd in neural tissue both stimulating 
glial activation and neuronal death. In addition, the present results provide 
the first evidence that during the human development Cd does not deserve 
just a neurotoxic role but also a central role in controlling the fate of glial 
cells, through the regulation of  astrocytes. This findings shed new light on 
the possible link between chemicals and neurodevelopmental disorders. 
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In this study we demonstrate that Cd treatment induces an increase of 
apoptotic markers expression (NGFRp75, caspase 8 and PARP) in human 
foetal spinal cord. Specific markers for motor neurons appear decreased  
after Cd exposure confirming that apoptosis specifically affects motor 
neurons of the ventral horns; Cd-induced apoptosis is associated to a 
significant gliosis as demonstrated by a significant increase of GFAP 
expression. Cd exposure significantly affects the ratio motor neurons/glial 
cells in human spinal cord at early stages of development; the decreased 
number of motor neuron as well as the increased of gliosis observed in the 
ventral horns may deeply affect function and development of human foetal 
spinal cord. Motor neurons death as well as proliferation of glial cells 
observed in this study after Cd treatment, may be explained considering the 
molecular mechanism of Cd. In fact, Cd ion easily substitutes for the 
Calcium and Zinc ions in several biological systems because it carries the 
same charge and it has a similar radius. For its ability in substituting and/or 
displacing Calcium and Zinc, Cd is involved in the generation of reactive 
oxygen species, inhibition of DNA repair enzymes, deregulation of cell 
proliferation as well as DNA methylation.  
Disregulation of Calcium and abnormal Calcium homeostasis are decisive 
in long-term neurodegeneration diseases such as Alzheimer’s disease, 
Parkinsons’s disease, Huntington’s disease, and ALS. During CNS 
development, when the permeability of BBB is changing, Cd,  interfering 
 115 
with biochemical events where Calcium or Zinc are involved, may deeply 
affect the developing of nervous structures. 
 
 
 
5 DISCUSSION 
Cadmium (group IIB of the periodic table of elements) is a heavy metal 
posing severe risks to human health. Up to this day, it could not be shown 
that cadmium has any physiological function within the human body. 
Interest has therefore risen in its biohazardous potential.  
Cadmium is regularly found in ores together with zinc, copper and lead. 
Therefore volcanic activity is one natural reason for a temporary increase in 
environmental cadmium concentrations. Cadmium is widely used in 
industrial processes, e.g.: as an anticorrosive agent, as a stabilizer in PVC 
products, as a colour pigment, a neutron-absorber in nuclear power plants, 
and in the fabrication of nickel-cadmium batteries. Phosphate fertilizers 
also show a big cadmium load. Although some cadmium-containing 
products can be recycled, a large share of the general cadmium pollution is 
caused by dumping and incinerating cadmium-polluted waste. In 
Scandinavia for example, cadmium concentration in agricultural soil 
increases by 0.2% per year.  
Principally there are two possible ways of cadmium resorption: 
gastrointestinal and pulmonary. The uptake through the human 
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gastrointestinal is approximately 5% of an ingested amount of cadmium, 
depending on the exact dose and nutritional composition. Several factors 
can increase this amount, such as low intakes of vitamin D, calcium, and 
trace elements like zinc and copper. Concerning zinc and calcium, it is 
assumed that their molecular homology could be a reason for a 
compensatory higher cadmium resorption. Furthermore a high fiber diet 
increases the dietary cadmium intake. The most important metabolic 
parameter for cadmium uptake is a person's possible lack of iron. People 
with low iron supplies showed a 6% higher uptake of cadmium than those 
with a balanced iron stock. This is the main reason for the higher cadmium 
resorption in people with anaemia and habitual iron deficit, such as 
children or menstruating women. Low iron blood levels stimulate the 
expression of DCT-1, a metal ion transporter in the GI tract, serving as a 
gate for cadmium resorption. The major source of inhalative cadmium 
intoxication is cigarette smoke. The human lung resorbes 40–60% of the 
cadmium in tobacco smoke. Smokers generally have cadmium blood levels 
4–5 times those of non-smokers. Workers exposed to cadmium-containing 
fumes have been reported to develop acute respiratory distress syndromes 
(ARDS). Once taken up by the blood, the majority of cadmium is 
transported bound to proteins, such as Albumin and Metallothionein. 
The first organ reached after uptake into the GI-blood is the liver. Here 
cadmium induces the production of Metallothionein. After consecutive 
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hepatocyte necrosis and apoptosis, Cd-Metallothionein complexes are 
washed into sinusoidal blood. From here, parts of the absorbed cadmium 
enter the entero-hepatical cycle via secretion into the biliary tract in form of 
Cadmium-Glutathione conjugates. Enzymatically degraded to cadmium-
cysteine complexes in the biliary tree, cadmium re-enters the small 
intestines. The cadmium concentration increases in the renal cortex, retina 
and other body tissues with age. There is some proof that cadmium can 
cause cancer. Some publications suggested an association of cadmium and 
renal cancer in humans. Consequently, the IARC (International Agency for 
Research on Cancer) decided to classify cadmium as a human carcinogen 
group I. Latest data however supports the assumption that only an uptake of 
cadmium via the respiratory system has carcinogenic potential. 
 
This research provides confirmations about the potential risk for human 
health caused by cadmium exposure. More studies are necessary to 
elucidate the mechanisms at the basis of cadmium toxicity.  
At present our research on the biological effects of cadmium on different 
cells, tissues and organs experimental models adopt primary human 
neurons from foetal basal nuclei as experimental model. 
Thanks to a collaboration with an English research group another 
experimental model recently adopted includes the study of cadmium 
exposure on primary (murine) retinal ganglion neurons. The evaluation of  
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the morphology, cell proliferation and angiogenic potential after CdCl2 
exposure performed by our research group is integrated by 
electrophysiological analyses on ion channels performed by the English 
scientific group.  
For this reason this PhD thesis was written in English language. 
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